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Microbial Regulation of Allergic Inflammation
Abstract
Allergic diseases have reached pandemic levels and represent a significant source of morbidity, mortality
and healthcare cost. These chronic inflammatory diseases are characterized by interleukin (IL)-4, IL-5, IL-9
and IL-13 production by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE) production by B cells,
and the recruitment of effector cells to sites of tissue inflammation. In addition to host genetic
polymorphisms and environmental triggers, studies in patients and model systems suggest that
commensal bacterial-derived signals influence susceptibility to TH2 cytokine-mediated allergic
inflammation. For example, patients with allergies display altered commensal bacterial populations and
antibiotic treatment increases allergy susceptibility. However, the influence of antibiotic treatment on
intestinal bacterial communities, and subsequent effects on innate immune cells that influence the
development of allergic inflammation, are poorly defined. Chapter 2 describes the development and
characterization of a new murine antibiotic treatment model using 454 deep sequencing techniques and
details antibiotic-induced temporal and spatial alterations to bacterial communities colonizing the murine
intestine. Having characterized the effects of antibiotic treatment on commensal populations, Chapter 3
and Chapter 4 examine the cellular and molecular mechanisms through which innate immune cells
respond to commensal-derived signals and regulate TH2 cytokine-mediated allergic responses. Data in
Chapter 3 describe antibiotic-induced steady-state elevations in serum IgE levels and circulating basophil
populations, an innate granulocyte implicated in contributing to allergic TH2 cell responses, as well as
exaggerated basophil-mediated inflammation in models of allergic disease. Data in Chapter 4 indicate
that circulating basophil populations correlate with serum IgE levels in mice and patients with hyper-IgE
syndrome, and that B cell-intrinsic MyD88 expression limits murine IgE levels and basophil responses.
These results provide novel mechanistic insights into how commensal bacterial-derived signals influence
TH2 cytokine-mediated allergic inflammation, and have implications for the development of new
preventative or therapeutic interventions for allergic disease.
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ABSTRACT
MICROBIAL REGULATION OF ALLERGIC INFLAMMATION

David Andrew Hill

Mentor: David Artis, Ph.D.

Allergic diseases have reached pandemic levels and represent a significant
source of morbidity, mortality and healthcare cost. These chronic inflammatory
diseases are characterized by interleukin (IL)-4, IL-5, IL-9 and IL-13 production
by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE) production by B
cells, and the recruitment of effector cells to sites of tissue inflammation. In
addition to host genetic polymorphisms and environmental triggers, studies in
patients and model systems suggest that commensal bacterial-derived signals
influence susceptibility to TH2 cytokine-mediated allergic inflammation. For
example, patients with allergies display altered commensal bacterial populations
and antibiotic treatment increases allergy susceptibility. However, the influence of
antibiotic treatment on intestinal bacterial communities, and subsequent effects
on innate immune cells that influence the development of allergic inflammation,
are poorly defined. Chapter 2 describes the development and characterization of
a new murine antibiotic treatment model using 454 deep sequencing techniques
and details antibiotic-induced temporal and spatial alterations to bacterial
v

communities colonizing the murine intestine. Having characterized the effects of
antibiotic treatment on commensal populations, Chapter 3 and Chapter 4
examine the cellular and molecular mechanisms through which innate immune
cells respond to commensal-derived signals and regulate TH2 cytokine-mediated
allergic responses. Data in Chapter 3 describe antibiotic-induced steady-state
elevations in serum IgE levels and circulating basophil populations, an innate
granulocyte implicated in contributing to allergic TH2 cell responses, as well as
exaggerated basophil-mediated inflammation in models of allergic disease. Data
in Chapter 4 indicate that circulating basophil populations correlate with serum
IgE levels in mice and patients with hyper-IgE syndrome, and that B cell-intrinsic
MyD88 expression limits murine IgE levels and basophil responses. These
results provide novel mechanistic insights into how commensal bacterial-derived
signals influence TH2 cytokine-mediated allergic inflammation, and have
implications for the development of new preventative or therapeutic interventions
for allergic disease.
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Chapter 1: An introduction to commensal
bacteria and the immune system

1

Microbes are the most abundant life form on earth. While many are free living, some
have evolved to participate in close and often long-lasting interactions with multicellular
hosts. Though some of these microbes have evolved as pathogens, others have evolved
commensal relationships that are essential to normal host development and physiology.
The existence of such symbiotic relationships with microbes is a conserved feature of
multicellular organisms including plants (Paszkowski 2006), insects (Muyskens,
Guillemin 2008), nematodes (Rae et al. 2008), fish (Bates et al. 2007), birds (Brisbin,
Gong & Sharif 2008), and mammals (Hill, Artis 2010). The mammalian intestine is
colonized by both the largest and most complex symbiotic microbial community
comprised of approximately 1014 bacteria and numerous viral and parasitic microbes. In
mammals, these microbes supply essential nutrients, aid in the digestion of otherwise
indigestible compounds, promote angiogenesis and enteric nerve function, defend
against opportunistic pathogens, and influence the development and homeostasis of the
immune system (Hill, Artis 2010, Hooper, Gordon 2001, Macpherson, Harris 2004).
To maintain immunologic homeostasis, the mammalian immune system has
evolved complex immunosurveillance networks able to respond to pathogens while
maintaining tolerance to commensals and environmental antigens. When these
mechanisms fail, host immune responses to commensal-derived signals can contribute
to the development of multiple human diseases including inflammatory bowel disease
(IBD) (Manichanh et al. 2006, Hanauer 2006), obesity (Ley et al. 2005), cancer (Moore,
Moore 1995), diabetes (Bollyky et al. 2009), and allergy (Penders et al. 2007, Marra et
al. 2009). This thesis focuses on commensal bacteria that colonize the mammalian
intestine, and the role that commensal bacterial-derived signals play in limiting TH2
cytokine-dependent allergic responses. Understanding the mechanisms by which

2

commensal-derived signals influence the mammalian immune system is essential to
both fully understand mammalian physiology, and to better define the etiology of human
inflammatory diseases in an effort to develop new preventative or therapeutic
approaches.
Potentially detrimental alterations to commensal bacterial communities that result
from antibiotic exposure are of particular medical relevance given recent epidemiological
associations between antibiotic treatment and the development of allergic disease
(Marra et al. 2009, Kummeling et al. 2007). However, the influence of oral antibiotic
treatment on qualitative and quantitative measures of commensal bacterial communities
is poorly defined. Therefore, Chapter 2 of this thesis describes the development of a
new murine oral antibiotic treatment model and the characterization of the subsequent
effects on commensal bacterial communities that colonize the murine intestine. Having
characterized the effects of antibiotic treatment on intestinal bacterial communities, the
remainder of this thesis utilizes oral antibiotic treatment and germ-free mouse models to
investigate the influence of commensal bacterial-derived signals on innate granulocyte
populations known to contribute to the initiation or propagation of TH2 cytokinedependent allergic responses. Data in Chapter 3 indicate that antibiotic treatment
results in steady-state increases in serum IgE levels and circulating basophil
populations, an innate granulocyte implicated in contributing to the development or
propagation of TH2 cell responses. Consistently, antibiotic-treatment resulted in
exaggerated basophil-mediated inflammation in three murine models of allergic disease.
Finally, the molecular and cellular mechanisms by which the mammalian immune
system recognizes commensal bacterial-derived signals and limits circulating basophil
populations are the focus of Chapter 4. Circulating basophil populations correlated with
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serum IgE levels in mice and DOCK8- humans, and B cell-intrinsic MyD88 expression
was identified as a regulatory pathway that limits murine IgE levels and basophil
responses. Together, these results provide novel mechanistic insights into how
commensal

bacterial-derived

signals

influence

T H2

cytokine-mediated

allergic

inflammation, and have broad implications for the development of new preventative or
therapeutic interventions for allergic disease.
In the remainder of Chapter 1, I first review previously published data supporting
a role for commensal bacteria in influencing the development or progression of human
disease. I then give an overview of commensal bacterial acquisition and detection of
commensal bacterial-derived signals by the host immune system. Next, I discuss data
from germ-free or antibiotic-treated mouse models that indicate a role for commensalderived signals in influencing the development and/or homeostasis of specific host
immune cell populations. Finally, I review basophil physiology and what is known of how
basophils cooperate with other innate immune cell types to influence the development
and/or propagation of TH2 cytokine-dependent inflammatory responses.

1.1 Intestinal bacteria in health and disease
Over the past century, studies of humans and animal models have identified important
roles for commensal bacterial communities in promoting the optimal digestion of food
(Hooper, Midtvedt & Gordon 2002), maintenance of epithelial homeostasis (Artis 2008),
modulating

fat

metabolism

(Backhed

et

al.

2004),

promoting

angiogenesis

(Stappenbeck, Hooper & Gordon 2002) and enteric nerve function (Husebye, Hellstrom
& Midtvedt 1994), supporting resistance to infection (Sekirov et al. 2008) and promoting
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normal development and homeostasis of the host immune system (Hill, Artis 2010,
Cebra 1999) (Figure 1). Given these important roles for commensal-derived signals in
maintaining normal host physiology, it is not surprising that perturbations to commensal
communities have been implicated as both a bio-marker for, and a potential contributing
factor to multiple human diseases. In this section, what is known of the role that
commensal bacterial-derived signals play in the pathophysiology of inflammatory bowel
disease and allergy are discussed as models of intestinal and systemic human disease
states, respectively.

Figure 1: Intestinal bacteria in mammalian health and disease
Schematic of the known influences of intestinal bacteria on normal mammalian physiology and
disease states. Adapted from (Hill, Artis 2010).

5

Inflammatory bowel disease (IBD; Crohn’s Disease and Ulcerative Colitis) is
thought to result in part from inappropriate and ongoing mucosal immune responses to
commensal intestinal bacteria (Podolsky 2002). IBD patients have altered commensal
bacterial communities compared to healthy individuals and tolerance to intestinal
bacteria is broken in IBD leading to inappropriate local and systemic immune responses
to commensal-derived signals (Macpherson et al. 1996)(Manichanh et al. 2006,
Macpherson et al. 1996, Duchmann et al. 1995, Lodes et al. 2004, Adams et al. 2008).
For example, IBD patients display aberrant cytokine production, T cell activation, and
mucosal and systemic antibody responses to intestinal bacterial-derived antigens
(Macpherson et al. 1996, Duchmann et al. 1995). Consistent with commensal-bacterial
derived signals being a precipitating factor in IBD, antibiotic therapy designed to deplete
the commensal bacterial load is a component of IBD therapeutic regimens (Talley et al.
2011). Despite these findings, the molecular and cellular causes of the dysregulated
immune responses to commensal bacteria observed in IBD patients are not fully
understood, however, polymorphisms in innate pattern recognition receptors are
associated with susceptibility to IBD. Most notably, mutations in NOD2, a component of
the innate immune system that is important for immune recognition and responses to
intracellular bacteria, are associated with increased risk of IBD development (Ogura et
al. 2001, Hugot et al. 2001, Hisamatsu et al. 2003). These findings implicate
inappropriate recognition of commensal-derived signals, and subsequent priming and
activation of the adaptive immune system, as central to IBD pathogenesis.
Animal models have supported a role for inappropriate immune responses to
commensal bacterial-derived signals in contributing to IBD pathogenesis. For example,
akin to the antibiotic treatment in human IBD patients, reducing commensal stimulation
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in several murine models of IBD, achieved by rearing animals under germ-free
conditions or via oral antibiotic treatment, ameliorates intestinal disease. This is the case
with IL-2-deficient mice that spontaneously develop intestinal inflammation when raised
under conventional conditions, but have a delayed and more mild disease course when
raised under germ-free conditions (Schultz et al. 1999). Similarly, IL-10-deficient mice
also develop spontaneous colitis associated with inappropriate T cell responses when
maintained under conventional conditions, but are protected against disease when
maintained under germ-free conditions or when treated with oral antibiotics (Dianda et
al. 1997, Sellon et al. 1998, Madsen et al. 2000, Hoentjen et al. 2003). These findings
support the view that inappropriate immune responses to commensal-derived signals
contribute to the development or progression of disease in these immunologically
impaired hosts.
Pathogenic commensal communities can also initiate disease states in hosts with
an intact immune system. For example, immunodeficient mice deficient in the
inflammatory transcription factor T-bet and the recombinase-activating gene RAG2
(TRUC mice) develop spontaneous colitis that is ameliorated by antibiotic treatment
(Garrett et al. 2007). Importantly, when wild-type mice are fostered by or co-housed with
TRUC mice they develop colitis, indicating that vertical or horizontal transmission of
colitogenic bacterial communities can cause disease in immunocompetent animals
(Garrett et al. 2007). This observation indicates that alterations in commensal bacterial
communities might not only be a consequence of disease, but that normal commensal
communities may protect against the development of colitis in healthy individuals.
Consistent with this, disruption of commensal communities via antibiotic treatment
increases patient risk of developing Clostridium difficile colitis, and alteration of
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commensal populations has been implicated in precipitating IBD in select cases (De La
Cochetiere et al. 2008, Hviid, Svanstrom & Frisch 2011).
In addition to influencing intestinal inflammatory responses, commensal-derived
signals have also been implicated in influencing susceptibility to asthma and other
systemic atopic disorders in humans (Penders et al. 2007). Allergic diseases have
reached pandemic levels and represent a significant source of morbidity, mortality, and
healthcare cost (Eder, Ege & von Mutius 2006, Bahadori et al. 2009). The development
of allergies is determined by interactions between genetic and environmental factors. For
example, allergy susceptibility is associated with genetic polymorphisms in more than 33
genes including HLA alleles and components of allergic cytokine signaling pathways
(Vercelli 2008). Additionally, environmental stimuli including pollutants, diet, and infection
history can influence susceptibility to allergic disease (Gilliland 2009, Zeiger 2003,
Harnett, Harnett 2010). More recently, alterations in the composition or quantity of
intestinal commensal bacterial communities have been implicated in contributing to
allergy susceptibility (Hill, Artis 2010, Round, Mazmanian 2009). However, the cellular
and molecular mechanisms by which commensal bacteria influence allergic inflammation
are poorly understood.
Allergic patients display altered commensal bacterial community structure in the
intestine, and infants who go on to develop allergies display altered commensal bacterial
community structure early in life (Penders et al. 2007, Kalliomaki et al. 2001).
Additionally, antibiotic exposure modifies commensal bacterial community structure of
the intestine and significantly correlates with increased risk of allergy development in
children, implicating commensal bacterial-derived signals in influencing susceptibility to
allergic diseases (Marra et al. 2009, Kummeling et al. 2007, Hill et al. 2009). In some
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cases, specific bacterial groups have been identified as potential contributors to allergy
susceptibility. For example, associations have been found between colonization with
Bifidobacterium, C.

difficile or Escherichia coli, and the development of eczema in

humans (Penders et al. 2007, Gore et al. 2008, Penders et al. 2008).
Animal models have provided additional insights into defined species of
commensal bacteria, and specific commensal-derived signals, which influence allergic
responses. Antibiotic treatment of mice results in exaggerated food allergy-like
symptoms characterized by increased levels of allergen-specific IgE in the serum
compared to conventionally-reared mice (Sudo et al. 1997). TLR4 signaling is important
for commensal bacterial-derived signals to promote oral tolerance as TLR4-deficient
mice display similar levels of food allergy compared to mice treated with oral antibiotics
(Bashir et al. 2004). Similarly, commensal bacterial-derived signals also seem to limit
disease in models of allergic asthma. Antibiotic treatment resulted in the selective
outgrowth of fungal microbes in the intestine and worse disease outcomes in an IL-13dependent mechanism (Noverr et al. 2005). Despite these strong epidemiologic and
experimental associations between alterations in commensal bacterial populations and
allergic inflammation, relatively little is known about the molecular and cellular
mechanisms by which the innate immune system recognizes commensal bacterialderived signals and influences the development TH2 cytokine-dependent allergic
inflammation.
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1.2 Commensal bacteria and the mammalian host
1.2.1 The bacterial composition and colonization dynamics of the mammalian
intestine
After birth, the epithelial surfaces of mammals are colonized with viruses, fungi, bacteria,
protozoa, and helminth parasites creating complex microbial communities in multiple
environmental niches. Several terms have been used to describe relationships between
microbes that colonize multicellular organisms, but for the purposes of this thesis
―commensal‖ is used to describe a mutualistic relationship within which the microbe
provides some benefit to the host. The mammalian gastrointestinal (GI) tract is the best
studied of these microbial environments. By adulthood, the GI tract is colonized by
members of all three domains of life; though intestinal bacterial communities are both the
most abundant and best characterized of microbial community (Whitman, Coleman &
Wiebe 1998), and as a result are the primary focus of this thesis.
Though exposed to bacteria throughout life, mammals are thought to undergo
two dominant phases of intestinal colonization; the first during breast milk or formula
feeding and the second upon weaning to solid foods. Mammalian breast milk is both a
source of defined microbes and of passive immunity in the form of immunoglobulins and
other maternal-derived molecules that shape developing intestinal communities (Diaz et
al. 2004, Martin et al. 2007b, Martin et al. 2007a). The temporal and spatial patterns of
intestinal colonization in infants are variable between individuals (Palmer et al. 2007)
and dependent upon multiple factors including country of birth (Benno et al. 1986),
length of gestation (Penders et al. 2006, Stark, Lee 1982a, Blakey et al. 1982), mode of
delivery (Penders et al. 2006, Gronlund et al. 1999), history of hospitalization (Penders
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et al. 2006), antibiotic use (Penders et al. 2006) and feeding practices (Penders et al.
2006, Hayashi, Sakamoto & Benno 2002a, Harmsen et al. 2000, Lundequist, Nord &
Winberg 1985, Stark, Lee 1982b, Yoshioka, Iseki & Fujita 1983, Penders et al. 2005).
For example, vaginally born and breast-fed infants have a predominance of
Bifidobacteria in their intestine, with lower contributions of E. coli, Bacteroides, and
Clostridia species while infants delivered by cesarean section have delayed colonization
kinetics compared to vaginally born infants and persistent changes to bacterial
communities including lower burdens of Bifidobacteria and Bacteroides groups, and
higher burdens of C. difficile (Penders et al. 2006, Gronlund et al. 1999, Bullen, Tearle &
Willis 1976). Though these individuals likely acquire normal adult bacterial communities
upon transition to solid foods, these differences may not be without consequence as
associations between early alterations to intestinal bacterial communities and increased
risk of allergic disease have been identified (Renz-Polster et al. 2005, Salam et al.
2006).
At maturity, the bacterial burden of the mammalian GI tract is estimated at over
100 trillion individual organisms at a density of 1011 to 1014 cells per gram of luminal
contents (Whitman, Coleman & Wiebe 1998, Eckburg, Lepp & Relman 2003). Studies
carried out as early as the 1960’s using culture-based and microbiological identification
methods identified Lactobacilli, Streptococci and members of the Bacteroides genus as
residents of the normal adult human intestine (Dubos et al. 1965). However, a large
percentage of intestinal bacteria are anaerobes that lack the enzymes necessary for the
detoxification of oxygen. As such, even under ideal conditions it is estimated that only
half of intestinal bacteria are culturable indicating that these early studies were limited in
their sensitivity (Adlerberth, Wold 2009).
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More recently, molecular advances in DNA bar coding and 454 pyrosequencing
of 16S ribosomal RNA gene segments are allowing previously unattainable insights into
both culturable and non-culturable bacterial communities of the mammalian intestine
(Hayashi, Sakamoto & Benno 2002b, Hold et al. 2002, Wang et al. 2003, Eckburg et al.
2005). These studies have identified the Firmicutes and Bacteroidetes phyla as the
major bacterial groups present in the mammalian intestine (Figure 2) but are placing
total species estimates from conservative numbers of 1000-2000 to numbers as high as
15,000-40,000 individual members (Hayashi, Sakamoto & Benno 2002b, Hold et al.
2002, Wang et al. 2003, Eckburg et al. 2005, Frank, Pace 2008). Of the Firmicutes, 95%
belong to the Clostridia class, while there are large variations in the Bacteroidetes
phylotypes among individuals (Hayashi, Sakamoto & Benno 2002b, Hold et al. 2002,
Eckburg et al. 2005, Finegold, Sutter & Mathisen 1983). Other phyla present in relatively
low

abundance

include

the

Proteobacteria,

Actinobacteria,

Fusobacteria,

and

Verrucomicrobia (Hayashi, Sakamoto & Benno 2002b, Wang et al. 2003, Eckburg et al.
2005, Finegold, Sutter & Mathisen 1983, Suau et al. 1999). The complexity of intestinal
bacterial communities suggests intimate coevolution between commensal communities
and mammalian hosts, and supposes that alterations in commensal bacterial
communities could impact numerous facets of mammalian physiology.
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Figure 2: The composition of bacterial communities along the length and between luminal and
mucosal compartments of the mammalian intestine
Stool pellet, luminal content, or mucosal-associated communities were sterilely collected. Total
sample DNA was extracted and bacterial 16S rDNA fragments were PCR amplified with bar codetagged primers, subjected to pyrosequencing, and taxonomic assignments for each sequence
were determined using RDP Classifier. (a) Commonly found bacteria in the murine colon. (b)
Relative frequencies and distribution of bacteria along the length of the murine colon. (c)
Relative frequencies and distribution of bacteria between luminal and mucosal-associated
compartments of the murine colon. Adapted from (Hill, Artis 2010).

Intestinal bacterial communities exhibit differences along the length of the colon
and differ significantly between the luminal and tissue attached microenvironments
suggesting that defined microbial communities at different anatomical locations may be
important for distinct aspects of normal mammalian physiology (Figure 2b,c) (Eckburg
et al. 2005, Zoetendal et al. 2002, McKenna et al. 2008). For example, while Lactobacilli
have been cited for potential probiotic effects, and can be isolated from approximately
80% of adults, they represent a relatively low proportion of luminal bacteria (Finegold,
Sutter & Mathisen 1983, Kuitunen et al. 2009). However, this group represents a
significant proportion (up to 13%) of mucosal-associated bacteria (Figure 2) indicating
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that colonization of this anatomical niche may be important for Lactobacilli’s potentially
beneficial physiologic effects for the host (Hill et al. 2009). To maintain homeostasis with
colonizing bacteria, mammals have evolved complex compensatory responses to
commensal-derived signals (Hill, Artis 2009). The host immune response to microbial
colonization will be discussed in the next section.

1.2.2 The host immune response to microbial colonization
The initial immune response to bacterial colonization by the mammalian host
peaks within a week of birth and subsequently stabilizes over the first year of life (Shroff,
Meslin & Cebra 1995). Initially, the host mounts an innate immune response to bacterial
colonization that is important for maintenance of the mucosal barrier (reviewed in (Dann,
Eckmann 2007)). This includes direct detection of commensal-derived signals by
intestinal epithelial cells via cell-autonomous MyD88 activation resulting in increased
expression of the antimicrobial peptides REGIIIγ and RELMβ (Wang et al. 2005,
Vaishnava et al. 2008). Additionally, the host mounts an adaptive immune response
characterized by production and secretion of IgA into the intestinal lumen (Macpherson
2006). IgA production occurs in response to small numbers of intestinal bacteria that
initially penetrate the intestinal epithelium where they are phagocytosed by DCs that
initiate IgA responses through T cell-dependent and -independent mechanisms
(Renshaw et al. 1994, Macpherson et al. 2000, Macpherson, Uhr 2004a, MacPherson et
al. 2004, Macpherson, Uhr 2004b, Bergqvist et al. 2006). In contrast to disease states
such as IBD, these B cell responses are limited to the mesenteric lymph nodes (mLNs)
and do not occur in systemic secondary lymphoid structures, indicating that induction of
this commensal-specific IgA response is compartmentalized to mucosal tissues under
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normal physiological conditions (Macpherson, Uhr 2004b, Konrad et al. 2006). Secretion
of IgA into the intestinal lumen acts as a homeostatic feedback loop to reduce epithelial
penetration by intestinal bacteria, and subsequent host inflammatory responses
(Macpherson et al. 2001). The initiation of these homeostatic responses is critically
dependent on recognition of commensal-derived signals by immune cells via innate
pattern recognition receptors. Innate recognition of commensal bacterial-derived signals
by pattern recognition receptors is reviewed in the next section.

1.3 Recognition of commensal-derived signals by pattern recognition
receptors
As discussed above, the colonization of the mammalian intestine results in a rapid
compensatory response by the mucosal immune system that is important for maintaining
mucosal integrity and immune homeostasis. A component of this innate response is the
recognition of microbial-derived cell wall components, DNA segments, and metabolites
by host pattern recognition receptors (PRRs) including Toll-like receptors, Nod-like
receptors, and G protein coupled receptors. This section reviews commensal bacterialderived signals, the innate receptors that recognize them, and focuses on the role that
intestinal epithelial cells (IECs) and dendritic cells (DCs) play in responding to these
signals and modulating subsequent immune responses.

1.3.1 Recognition of commensal-derived signals by Toll-like receptor ligands
Toll-like receptors (TLRs) are innate pattern recognition receptors that bind evolutionarily
conserved motifs found in bacteria and other microbes (Medzhitov, Preston-Hurlburt &
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Janeway 1997). TLRs have evolved to recognize multiple microbial-derived signals
including double-stranded viral RNA (TLR3), gram-negative lipopolysaccharide (LPS)
(TLR4), and gram-negative and gram-positive flagellin (TLR5) (West, Koblansky &
Ghosh 2006). Most TLRs are expressed on the surface of cells with the exception of
TLR3, 7, 8, and 9 which are localized to endolysosomal compartments (Medzhitov
2007).
Studies in humans and animal models have implicated TLRs as important
modulators of both physiologic and pathologic host immune responses to commensal
bacteria. In some cases, recognition of commensal-derived signals by TLRs contributes
to disease states. For example, dominant-negative TLR5 polymorphisms in humans
result in reduced responses to flagellin, and protect against the development of Crohn’s
disease (Gewirtz et al. 2006). Consistent with these findings, studies in animal models
have shown that recognition of bacterial flagellin by TLR5 influences proinflammatory
gene expression by intestinal epithelial cells (Gewirtz et al. 2001). However, recognition
of bacterial-derived signals by TLRs can also be protective in other settings. For
example, LPS administration signals through TLRs to protect against chemically-induced
experimental colitis while treatment with flagellin (which signals via TLR5) protects
against chemical, bacterial, viral, and radiation-induced mortality in multiple animal
models (Rakoff-Nahoum et al. 2004, Vijay-Kumar et al. 2008). Finally, administration of
the TLR9 ligand CpG reduces severity of food allergy in TLR4-deficient mice (Bashir et
al. 2004). The potential protective roles for TLR signaling in disease have spurred
interest in TLR ligands as therapeutic agents and TLR ligands are currently being
investigated as treatments for both human allergy and as adjuvant therapies for cancer
(Racila, Kline 2005, Krieg 2007).
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1.3.2 Recognition of commensal-derived signals by NOD-like receptors
NOD-like receptors (NLRs) detect intracellular ligands and have been identified as key
mediators of proinflammatory and immunoregulatory responses in animals and humans
(Fritz et al. 2006). NLRs recognize several commensal bacterial-derived signals
including peptidoglycan containing meso-diaminopimelic acid (NOD1) and muramyl
dipeptide (NOD2) (Carneiro et al. 2008). In the setting of an invading pathogen, NOD2
ligation initiates NF-κB activation and upregulation of proinflammatory cytokines (Fritz et
al. 2006). Consistently, NOD-1 dependent recognition of commensal-derived signals has
been shown to be important for normal neutrophil-mediated killing of pathogenic bacteria
(Clarke et al. 2010). However, NOD-dependent signaling can also play a protective role
in various disease states. In humans, approximately 15% of patients with Crohn's
disease have homozygous or compound heterozygous mutations in the gene that
encodes NOD2 (CARD15) implicating NOD signaling in a protective role (Ogura et al.
2001, Hugot et al. 2001). Consistent with this hypothesis, chronic stimulation of NOD2
has been shown to mediate tolerance to bacterial products and NOD2-deficient mice
have an increased susceptibility to experimental colitis (Watanabe et al. 2006, Hedl et al.
2007, Watanabe et al. 2008). The mechanisms by which NOD-dependent signals can
have such diverse immunomodulatory outcomes are an active area of research. One
likely explanation is that NOD-dependent signals have different immune outcomes
depending on the broader immunological context in which they are acting (Watanabe et
al. 2006, Watanabe et al. 2004).
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1.3.3 Recognition of commensal-derived signals by GPCRs and other receptors
In addition to the TLR and NOD ligands, immunoregulatory G protein coupled receptor
(GPCR) ligands such as the purine adenosine (Ado) are of growing interest in the fields
of IBD and other inflammatory diseases (Jacobson, Gao 2006). Ado may function as an
endogenously generated regulator of inflammation with different immune outcomes
depending on the receptor it binds. For example, an Ado A2A receptor agonist did not
alter the course of chemical colitis while Ado A2B-deficient mice have increased
susceptibility to chemical colitis (Selmeczy et al. 2007, Frick et al. 2009). More recently,
intestinal bacteria were found to be a source of adenosine triphosphate (ATP) that can
drive TH17 cell differentiation in the lamina propria by inducing IL-6 and IL-23p19
production by a population of CD70 (high) CD11c (low) cells (Atarashi et al. 2008).
Accordingly, germ-free mice exhibit lower concentrations of luminal ATP, as well as
fewer numbers of TH17 cells in the LP, a defect that could be reversed through the
systemic or rectal administration of ATP (Atarashi et al. 2008).
Commensal bacteria that colonize the mammalian intestine also produce
significant amounts of butyrate, as well as other short chain fatty acids (Pryde et al.
2002). The receptor for butyrate, GPR109A, is expressed on IECs and is down regulated
in human colon cancer, in a mouse model of intestinal/colon cancer, and in colon cancer
cell lines (Avivi-Green et al. 2000, Hague et al. 1995). Consistent with the hypothesis
that GPR109A signaling suppresses tumor development or progression, expressing
GPR109A in colon cancer cells induces apoptosis in the presence of butyrate
(Thangaraju et al. 2009). Butyrate has been shown to have an immunoregulatory role in
the steady-state by signaling through GPR109A on IECs to suppress NF-κB signaling
(Thangaraju et

al. 2009,

Kumar et al. 2009). Consistent with a primarily
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immunoregulatory role, butyrate reduces production of TNFα, TNFβ, IL-6, and IL-1β by
lamina propria lymphocytes (LPLs) of IBD patients (Luhrs et al. 2002, Segain et al.
2000). Together, these findings indicate that butyrate inhibits tumorigenesis and limits
proinflammatory responses in the intestine.
Succinate, a component of the citric acid cycle, is a commensal metabolite that
has been shown to modulate dendritic cell function by signaling through the extracellular
GPCR GPR91. In one study, succinate signaling triggered intracellular calcium release,
induced DC migratory responses, and acted in synergy with TLR ligands to induce the
production of proinflammatory cytokines by DCs (Rubic et al. 2008). Succinate also
enhanced antigen-specific activation of human and mouse helper T cells, while GPR91deficient mice had reduced Langerhan cell migration to draining lymph nodes and
impaired tetanus toxoid-specific recall T cell responses (Rubic et al. 2008). Together,
these results implicate the sensing of succinate through GPR91 as an important signal
of immunologic danger.
Finally, bacterial adhesion via surface proteins can directly modulate immune cell
function. For example, Lactobacillus acidophilus NCFM attaches to DCs resulting in
production of IL-10 and IL-12p70 (Konstantinov et al. 2008). The bacterial surface
component surface layer A protein (SlpA) was found to be sufficient for this
immunomodulatory function as purified SlpA protein bound and activated DCs directly
(Konstantinov et al. 2008). Consistently, T cells primed with DCs that were stimulated
with L. acidophilus NCFM lacking SlpA produced less IL-4 than those stimulated with
wild-type L. acidophilus NCFM (Konstantinov et al. 2008). In summary, commensalderived signals can have proinflammatory or immunoregulatory effects depending on the
immunologic context in which they act. I will next discuss how recognition of commensal-
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derived signals by IECs and DCs via innate PRRs influences the development of local
and systemic immune responses.

1.4 Recognition of commensal-derived signals by innate immune cells
1.4.1 Recognition of commensal-derived signals by intestinal epithelial cells
The intestinal epithelium has a diverse set of physiologic functions including digestion
and absorption of nutrients, the maintenance of a physical barrier from the external
environment, and immunological surveillance of intestinal bacteria and potential
pathogens. Intestinal epithelial cells (IECs) are continually replaced from a pool of Lgr5+
multipotent stem cells that reside in crypts of the intestine (Gordon, Hermiston 1994,
Sato et al. 2009). IECs utilize intercellular tight junctions to prevent paracellular traffic
and actin-rich microvillar extensions to create an apical brush border that impedes
microbial attachment and invasion (Shen, Turner 2006). As a result, selective uptake of
macromolecules, particulate antigens, and microorganisms across the intestinal epithelia
occurs primarily via active vesicular transport across epithelial cells, and as such is
restricted by multiple cellular and molecular mechanisms (reviewed in (Neutra, Pringault
& Kraehenbuhl 1996)).
In addition to physical adaptations that control transport across the epithelium,
biochemical adaptations have evolved including goblet cells, a cell type that produces a
heavily glycosylated, mucin-rich secretion that creates a relatively impermeable apically
adhered glycocalyx (Frey et al. 1996). The epithelium also produces antimicrobial
peptides including defensins, cathelicidins, and calprotectins that confer broad-spectrum
antimicrobial properties through the formation of pores in the bacterial cell wall (Ganz
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2003). These adaptations are consistent with the view that IECs, in addition to promoting
digestion and absorption of nutrients, perform essential barrier functions that obstruct the
entry of beneficial and pathogenic microorganisms into the underlying lamina propria.
IECs are in continuous contact with beneficial and pathogenic bacteria and, as a
result, are ideally located for ―immunologic surveillance‖ of the intestinal lumen. IECs
express TLRs, NLRs, and GPCRs that recognize microbial components and modulate
cellular responses (Figure 3) (Hisamatsu et al. 2003, Gewirtz et al. 2001, Cario,
Podolsky 2000). For example, IEC expression of innate pattern recognition receptors is
important for mounting immune responses to pathogenic microbes (Carneiro et al. 2008,
Zilbauer et al. 2007) by mediating the expression of pro-inflammatory cytokines,
chemokines, and antimicrobial peptides, as well as the modulating of other immune cell
types including the direct induction of IgA class switching by B cells (Macpherson et al.
2000, Medzhitov 2007, Fritz et al. 2006, He et al. 2007, Xu et al. 2007). Responses by
IECs to intestinal bacteria are not uniform however. IECs selectively initiate proinflammatory response to pathogenic bacteria while promoting tolerance to beneficial
bacteria (Shen, Turner 2006, Zilbauer et al. 2007, Jung et al. 1995). For example, the
gram-negative bacteria Bacteroides thetaiotaomicron which induces IEC expression of
the antimicrobial peptide REGIIIγ, while the gram-positive Bifidobacterium longum, a
common component of intestinal communities, does not (Cash et al. 2006, Sonnenburg,
Chen & Gordon 2006).
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Figure 3: Innate receptors and signaling cascades of mammalian intestinal epithelial cells
Schematic shows the location of innate pattern-recognition receptors and their signaling
cascades in mammalian IECs. Innate pattern-recognition receptors converge on a common NFκB signaling cascade to regulate transcription of proinflammatory or immunoregulatory
cytokines and chemokines. Adapted from (Hill, Artis 2010).

Two mechanisms by which IECs may discriminate between beneficial and
pathogenic bacteria are through subcellular sequestering of pattern-recognition
receptors away from luminal signals and by differential receptor expression. For
example, TLR5 (which recognizes bacterial flagellin) has been reported to be expressed
exclusively on the basolateral surfaces of IECs (Gewirtz et al. 2001). Additionally, TLR3,
7, 8 and 9 are expressed exclusively in intracellular endosomal organelles, while NLRs
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are localized to the cytoplasm. In all these cases, reducing exposure of these receptors
to luminal bacterial-derived signals limits pro-inflammatory responses to primarily
pathogenic settings (Medzhitov 2007, Philpott, Girardin 2004, Uehara et al. 2007). In
addition, under steady-state conditions, IECs are reported to express little or no TLR2,
TLR4, or CD14 further minimizing the recognition of bacterial LPS from beneficial
bacteria (Abreu et al. 2001, Melmed et al. 2003). However, subcellular localization and
differential expression alone cannot account for all discrimination between beneficial and
pathogenic bacteria by IECs as GPCRs that recognize and mount inflammatory
responses to bacterial products are continuously expressed on their apical surface. As
such, further investigation is necessary to fully understand how IECs operate in the
context of the mucosal immune system to discriminate against beneficial and pathogenic
bacteria.
The recognition of bacterial signals by IECs is essential to mucosal homeostasis
implicating IECs as central modulators of subsequent adaptive responses (RakoffNahoum et al. 2004, Bouskra et al. 2008, Cario, Gerken & Podolsky 2007). One
mechanism by which IECs can influence proinflammatory or immunoregulatory
responses is by influencing DCs, macrophages, and lymphocytes through the local
expression of immunoregulatory cytokines including thymic stromal lymphopoietin
(TSLP), IL-10, transforming growth factor β (TGFβ), prostaglandin E2 (PGE2), retinoic
acid or IL-25 (Zaph et al. 2008, Brown et al. 2007, Dignass, Podolsky 1993, Rimoldi et
al. 2005a, Rimoldi et al. 2005b, Taylor et al. 2009, Zeuthen, Fink & Frokiaer 2008a,
Zeuthen, Fink & Frokiaer 2008a). For example, monocyte-derived or circulating DCs
conditioned with supernatants from IECs isolated from healthy patients induced Foxp3+
Treg differentiation, while IECs from Crohn’s disease patients did not suggesting that
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IECs may condition DCs to have primarily immunoregulatory phenotypes under
physiologic conditions (Iliev et al. 2009b). This effect was dependent on the production
of TGFβ and retinoic acid by IECs, but not TSLP, as DCs deficient in the TSLP receptor
(TSLPR-/-) and wild-type DCs had a similar ability to convert naïve T cells into Treg cells
(Iliev et al. 2009a). Indeed, a population of intestinal DCs induced FoxP3+ Tregs in a
TGFβ and retinoic acid-dependent manner in vitro further implicating epithelial derived
signals in the conditioning of DCs and subsequent adaptive responses, while deletion of
NF-κB signaling specifically in IECs resulted in the dysregulated expression of DCderived proinflammatory cytokines and the development of spontaneous or infectioninduced intestinal inflammation (Nenci et al. 2007, Zaph et al. 2007, Sun et al. 2007,
Coombes et al. 2007). Together, these findings indicate that IECs play a crucial role in
conditioning intestinal DC responses.
Epithelial—derived TSLP has been shown to have important immunomodulatory
roles. High levels of Tslp mRNA are expressed by epithelial cells at the mucosal
surfaces of the skin, airways, and intestine and expression can be upregulated by
infection, inflammation or tissue injury in an NF-κB-dependent manner (Rimoldi et al.
2005b, Zaph et al. 2007, Li et al. 2006, Allakhverdi et al. 2007, Bogiatzi et al. 2007, Kato
et al. 2007, Lee, Ziegler 2007). In vitro studies have shown that TSLP-conditioned
human DCs can promote TH2 cell responses through the inhibition of IL-12 production
and the induction of OX40L expression (Rimoldi et al. 2005b, Soumelis et al. 2002, AlShami et al. 2005, Ito et al. 2005, Liu 2007). In vivo studies in the skin and lung have
shown that transgenic overexpression of TSLP in cutaneous or pulmonary epithelial cells
results in the onset of TH2 cytokine–mediated inflammation resembling atopic dermatitis
or asthma, respectively, suggesting that TSLP is both necessary and sufficient for the
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initiation of TH2 cytokine–driven inflammation in some settings (Soumelis et al. 2002, AlShami et al. 2005, Yoo et al. 2005, Zhou et al. 2005) (reviewed in (Ziegler, Liu 2006)).
Consistently, TSLP expression and TSLP-TSLPR interactions are important for immunity
to the intestinal nematode Trichuris muris, and protection against experimental colitis
through the in vivo inhibition of IL-12/23p40 production by DCs (Taylor et al. 2009, Zaph
et al. 2007). Another mechanism by which TSLP may influence TH2 cell responses is via
regulation of basophil development. It has recently been shown that TSLP enhances the
development of a bone marrow-resident basophil precursor in an IL-3-independent
manner (Siracusa et al. In Press). Compared to IL-3-elicited basophils, TSLP-elicited
basophils produce more IL-4 upon stimulation with IL-18 or IL-33, and were sufficient to
recover TH2 cell-dependent immunity to T. muris infection in a susceptible host model
system (Siracusa et al. In Press). Together, these results highlight the role of this
important epithelial-derived cytokine in mediating normal TH2 cytokine-dependent
allergic responses.
Finally, IECs are in direct contact with intraepithelial lymphocytes and express all
the molecular machinery required for antigen processing and presentation including
proteolytically active cathepsins, the invariant chain, and MHC class II molecules
(Hershberg, Mayer 2000). In vitro studies showed that rodent IECs, although less potent
than professional antigen-presenting cells, can process and present antigen through the
MHC class II pathway (Telega, Baumgart & Carding 2000). Supporting a role in directly
promoting T cell responses, IECs isolated from patients with IBD express MHC class II
molecules and can localize exogenous antigens to the late endosome on their
basolateral surfaces (Buning et al. 2006). However, the lack of costimulatory molecule
expression by IECs suggests IECs cannot prime naïve T cells under normal conditions,

25

though memory T cells exhibit less stringent requirements for co-stimulation and may
therefore be influenced by IEC-intrinsic antigen presentation (Sanderson et al. 1993,
Arens et al. 2011). Finally, IECs may deliver inhibitory or tolerogenic signals directly to T
cells consistent with their known role in controlling B cell responses (Xu et al. 2007).
Taken together, these studies describe how IEC-mediated recognition of commensalderived signals may influence the development and propagation of local or systemic
immune responses.

1.4.2 Recognition of commensal-derived signals by dendritic cells
Dendritic cells (DCs) are perhaps the most efficient modulators of adaptive immune
responses and they represent an important link between the innate and adaptive
immune systems (Trombetta, Mellman 2005). DCs that survey mucosal tissues take on
specific phenotypic characteristics and perform distinct functions depending on their
anatomical location. In the small intestine, DCs reside both in organized lymphoid
structures such as Peyer’s patches (PP) and are present directly beneath the epithelial
layer in the intestinal lamina propria (LP DCs) (Figure 4) (Coombes, Powrie 2008).
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Figure 4: The mucosal immune system of the mammalian intestine
Innate recognition of signals from intestinal bacteria takes place at the intestinal epithelium, in
the lamina propria and in gut-associated lymphoid tissues such as Peyer’s patches and isolated
lymphoid follicles. Specialized intestinal epithelial cells known as M (microfold) cells overlie
Peyer’s patches and lymphoid follicles and facilitate luminal sampling and transport of microbial
components to professional antigen-presenting cells present in the subepithelial dome (SED).
Dendritic cells (DCs) in the SED and perifollicular area (PFA) acquire antigens and influence
adaptive responses. Additionally, specialized DC subsets directly sample luminal antigens.
Intestinal DCs transport antigens to mesenteric lymph nodes through the afferent lymphatic
system. DCs in the mesenteric lymph node promote differentiation of regulatory and effector T
lymphocytes, as well as class switching of B lymphocytes, which then exit through the efferent
lymph into the systemic circulation. Some of these cells home back to the intestine where they
exert effector functions. Adapted from (Hill, Artis 2010).
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Peyer’s patch DCs are divided into three groups based on chemokine receptor
expression, anatomical location, and functional characteristics. CX3CR1+ PP DCs are
found in close contact with the follicle-associated epithelium (FAE) where they
participate in a close functional relationship with the epithelial M cell to sample luminal
antigens in a pattern recognition receptor-dependent manner (Milling, Cousins &
MacPherson 2005, Tyrer et al. 2006). CCR6+ PP DCs are found in the sub-epithelial
dome but can quickly migrate to the FAE in response to microbial stimulation, and
CCR7+ PP DCs are found in T cell areas where they orchestrate helper T cell responses
(Iwasaki, Kelsall 1999, Iwasaki, Kelsall 2000, Salazar-Gonzalez et al. 2006), T cell
migration (Johansson-Lindbom et al. 2005, Mora et al. 2003), and IgA in response to
microbial signals production (Spalding et al. 1984, George, Cebra 1991, Powrie 2004).
While DCs resident in the PP are important mediators of immune function, PPs
are relatively rare along the length of the intestinal tract. BrdU pulse-chase experiments
suggest that circulating DCs have evolved to migrate directly to the lamina propria (LP)
of the small intestine through the expression of CD103 (Jaensson et al. 2008). These LP
DCs express tight-junction proteins that allow for direct luminal sampling through the
extension of dendrites between IECs, a process that is dependent on the CX3Cchemokine receptor 1 (CX3CR1) and TLR ligation (Rescigno et al. 2001, Niess et al.
2005, Chieppa et al. 2006). Accordingly CX3CR1-/- mice exhibit defective luminal
sampling by DCs and impaired resistance to Salmonella typhimurium infection,
implicating a crucial role for luminal sampling in the development of protective immune
responses in the intestine (Niess et al. 2005).
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Intestinal DCs recognize bacteria through the expression of innate pattern
recognition receptors (Medzhitov 2007) which can modify luminal sampling (Chieppa et
al. 2006), migration (Turnbull et al. 2005, Yrlid et al. 2006), and the induction of T cell
differentiation (Minns et al. 2006, Uematsu et al. 2006, Uematsu et al. 2008). Intestinal
resident DCs are thought to be tolerogenic compared to systemically circulating DCs, a
phenotype that may be important for controlling inflammatory immune responses to
beneficial intestinal bacteria (Sun et al. 2007, Coombes et al. 2007). For example,
stimulation of intestinal DCs with the TLR4 ligand lipopolysaccharide (LPS) resulted in
elevated IL-10 production, while stimulation of systemic DCs resulted in proinflammatory activation (Monteleone et al. 2008, Takenaka et al. 2007). The
mechanisms by which intestinal DCs may be skewed towards a tolerogenic phenotype
are still under investigation and include reduced TLR expression (Monteleone et al.
2008, Takenaka et al. 2007), hyporesponsiveness to TLR stimulation (Cerovic et al.
2009), and/or negative regulation of the NF-κB pathway via NOD2 signaling (see section
1.3.2) (Watanabe et al. 2006, Watanabe et al. 2008, Watanabe et al. 2004, Zeuthen,
Fink & Frokiaer 2008b, Yang et al. 2007). Finally, as discussed in section 1.4.1, IECs
may play an active role in promoting the tolerogenic phenotype of intestinal DCs via
direct or indirect mechanisms (Iliev et al. 2009b).
Intestinal resident DC populations regulate local T cell responses in part through
the production of IL-12 and IL-23. IL-12 is a key regulatory cytokine that induces TH1 cell
differentiation and plays an important role TH1-mediated experimental models of
autoimmune diseases including inflammatory bowel disease (Neurath et al. 1995,
Simpson et al. 1998, Davidson et al. 1998, Trinchieri 2003, Elson et al. 2005). IL-23 is a
heterodimer cytokine composed of a p40 subunit (that is shared with IL-12) and a unique
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p19 subunit (Oppmann et al. 2000). While one study has implicated IL-23 to have a
protective role in a murine model of colitis (Becker et al. 2006), others have shown that
IL-23 drives inflammatory TH17 responses (Lyakh et al. 2008, Yen et al. 2006) (reviewed
in (Ahern et al. 2008)) and is a causative agent in a number of inflammatory disorders
including joint inflammation (Murphy et al. 2003), intestinal inflammation (Yen et al.
2006, Hue et al. 2006, Izcue et al. 2008, Kullberg et al. 2006, Uhlig et al. 2006), and
psoriasis (Chan et al. 2006, Kopp et al. 2003). The recent identification of the IL23R as a
gene that is associated with IBD risk has further increased clinical interest in IL-23
inflammatory axis (Duerr et al. 2006).
Importantly, both PP and LP DCs continuously transport self

and bacterial

antigens, as well as live bacteria, to the mesenteric lymph nodes where they can modify
systemic immune responses (Macpherson, Uhr 2004b, Trombetta, Mellman 2005,
Huang et al. 2000, Fujita et al. 2006, Jang et al. 2006). Intestinal bacteria have been
shown to induce lamina propria and mLN DCs to activate a maturation program that
promotes subsequent conversion of naïve CD4+ T cells into regulatory T cells in a
retinoic acid and TGF-β dependent manner (Sun et al. 2007, Coombes et al. 2007,
Coombes, Powrie 2008, Baba et al. 2008). Intestinal DCs in the mLNs can subsequently
target B and T lymphocytes back to the intestine by causing the upregulation of CCR9
and α4β7 (Johansson-Lindbom et al. 2005, Mora et al. 2003, Mora et al. 2006, Stagg,
Kamm & Knight 2002, Svensson et al. 2004). In summary, intestinal DCs have a
predominantly tolerogenic phenotype that is thought to be mediated in part through
signals from IECs or other immune cells as well as direct interactions with intestinal
bacteria. This unique characteristic is thought to be important for maintaining tolerance
to commensal bacterial-derived signals as well as other luminal antigens.
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1.5 The influence of commensal-derived signals on immune cell
development and homeostasis
As discussed above, signals from intestinal bacteria appear to influence human and
murine models of disease by modulating innate and adaptive immune responses. One
model used to study the role of microbial signals in immune cell development is the
germ-free mouse (reviewed in (Smith, McCoy & Macpherson 2007)). Germ-free mice are
born and live in a sterile environment and are therefore free of exposure to live microbial
signals (Macpherson, Harris 2004). As such, germ-free mice have been instrumental in
dissecting the role of bacterial signals in the development of the immune system.
Additionally, animals with altered intestinal communities, primarily achieved through the
administration of oral broad-spectrum antibiotics, have provided a complimentary
approach to germ-free studies and have identified key roles for bacterial signals in the
regulation of immune cell homeostasis (Sekirov et al. 2008, Hill et al. 2009, RakoffNahoum et al. 2004, Zaph et al. 2008, Hall et al. 2008). In this section, we review
findings from the germ-free and antibiotic-treatment mouse models that implicate
commensal-derived signals in supporting normal physiology of the mammalian immune
system.

1.5.1 The influence of commensal-derived signals on intestinal morphology and
function
Germ-free and antibiotic-treated mice display a number of morphologic defects as
compared to conventionally-reared animals. Perhaps most striking is the dramatic
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enlargement of the cecum (an intestinal segment located between the distal small
intestine and proximal colon) observed in these models. This enlargement is due in part
to the accumulation of undegraded mucus glycoproteins that are produced by the
intestinal epithelium and are normally degraded by glycoside hydrolases from intestinal
bacteria (namely Peptostreptococcus micros and members of the genera Ruminococcus
and Bifidobacterium) (Lindstedt, Lindstedt & Gustafsson 1965, Gustafsson, Midtvedt &
Strandberg 1970, Hoskins et al. 1985, Carlstedt-Duke et al. 1986). Accordingly, cecal
enlargement can be rapidly reversed through selective monoassociation with
Peptostreptococcus micros (Carlstedt-Duke et al. 1986). Germ-free animals also
accumulate bile acids in their cecum and large intestine which may contribute to cecal
distention by causing osmotic imbalances across the epithelial wall (Eyssen, Parmentier
& Mertens 1976).
Characteristic histologic alterations in the architecture of the intestinal epithelium
also occur in germ-free and antibiotic-treated animals. The villi of the cecum are longer
and wider compared to conventionally-reared mice and morphologic studies in rats
suggest that crypts are shorter and contain fewer cells in the germ-free as compared to
conventionally-reared animals (Alam, Midtvedt & Uribe 1994). These changes in crypt
architecture could also be in part due to decreased turnover of IECs that occurs in germfree as compared to conventionally-reared animals or due to anatomical defects
discussed above (Abrams, Bauer & Sprinz 1963).
In conventionally-reared animals, the intestine undergoes waves of peristalsis
that help move luminal contents proximally to distally. Intestinal bacteria modify enteric
nerve function and transient manipulations of intestinal communities can lead to
persistent neuromuscular dysfunction and enteritis (Barbara, Vallance & Collins 1997).
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Consistently, germ-free animals show defects in small intestinal peristalsis characterized
by slower and less frequent migrating motor complexes as a result of reduced
responsiveness to enteroendocrine cell products (Strandberg et al. 1966). Intestinal
motility is important for the maintenance of intestinal bacterial communities as the
ablation enteric neurons specifically in the jejunum and ileum resulted in bacterial
overgrowth and patchy jejuno-ileitis containing foci of hemorrhagic necrosis (Bush et al.
1998). Peristaltic defects can be reversed through conventionalization of germ-free
animals suggesting that bacterial signals dynamically influence intestinal neuromuscular
function (Husebye, Hellstrom & Midtvedt 1994).

1.5.2 The influence of commensal-derived signals on gut-associated lymphoid tissues
It is estimated that the intestinal mucosa of humans contains more lymphocytes, and
produces more antibodies, than any other organ in the body (Mestecky, McGhee 1987).
In mice, the majority of immune cells reside in gut-associated lymphoid tissues (GALT)
which include the mLN, Peyer’s patches (PP), cecal patch and isolated lymphoid follicles
(ILF) which occur along the length of the gastrointestinal (GI) tract with increasing
frequency in the colon and rectum (Langman, Rowland 1986, Brandtzaeg et al. 1989).
Germ-free

mice

display

reduced

intestinal

lymphatic

tissue

and

an

underdeveloped lymphatic system as compared to conventionally-reared mice
implicating commensal bacterial-derived signals in contributing to the development of
these structures (Hudson, Luckey 1964, Hooijkaas et al. 1984). Specifically, PP numbers
and cellularity are reduced, as are the number of ILFs (Bouskra et al. 2008, Cebra et al.
1998). Defects in lymphoid tissue genesis are not limited to the immediate intestinal
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compartment as mLNs are smaller, less cellular, and have fewer germinal centers in
germ-free compared to conventionally-reared animals (Glaister 1973). Consistently,
antibiotic treatment has been shown to decrease the cellularity of intestinal Peyer’s
patches, implicating bacterial signals in the maintenance of intestinal lymphoid tissues
(Yaguchi et al. 2006). These findings indicate that microbial signals are required for
lymphoid tissue development and/or maintenance in the mammalian intestine.
Several studies have begun to identify the bacterial-derived signals that
contribute to the maintenance of intestinal lymphoid tissues. For example, the selective
colonization of germ-free animals with intestinal bacteria results in the recovery of
lymphoid structures in the intestinal compartment and the recovery of mLN size and
cellularity (Hudson, Luckey 1964, Glaister 1973). Additionally, peptidoglycan from gramnegative bacteria have been shown to be both necessary and sufficient to induce ILF
formation in the mammalian intestine in a NOD1-dependent manner (Bouskra et al.
2008).

1.5.3 The influence of commensal-derived signals on dendritic cell and macrophage
differentiation and function
Signals from intestinal bacteria have both developmental and regulatory influences on
intestinal APCs. Intestinal DCs have been shown to be present in reduced numbers in
the intestine of germ-free compared to conventionally-reared animals (Haverson et al.
2007, Williams et al. 2006). These defects appear to be isolated to the intestinal
compartment as DCs from the spleen and mLNs of germ-free animals had normal
surface marker expression and ability to stimulate T cell proliferation (Walton et al.
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2006b). Intestinal DCs were recruited to the lamina propria upon monoassociation of
germ-free animals with E. coli suggesting that intestinal bacteria influence the
anatomical locations of intestinal DC populations (Haverson et al. 2007).
Monocyte/macrophage development is also influenced by signals from intestinal
bacteria. Monocyte/macrophage numbers in the intestine were either normal or reduced
in germ-free as compared to conventionally-reared animals (Williams et al. 2006, Zhang
et al. 2008). In addition, systemic monocyte/macrophage numbers are reduced in germfree as compared to conventionally-reared animals (Zhang et al. 2008). Again, systemic
and

intestinal

defects

in

monocytes/macrophage

could

be

recovered

upon

monoassociation of germ-free animals with L. acidophilus and L. reuteri implicating
signals from intestinal bacteria in the regulation of these cell types (Zhang et al. 2008).
As discussed previously, intestinal APCs are thought to have a uniquely
tolerogenic phenotype that is important for maintaining tolerance to oral antigens
(reviewed in (Medzhitov 2007, Takenaka et al. 2007)). For example, intestinal CD11c+
lamina propria cells expressed TLR5 and proinflammatory cytokines in response to
pathogenic bacteria, but not in response to beneficial bacteria (Uematsu et al. 2006). It is
thought that the tolerogenic nature of intestinal APCs may be imparted directly or
indirectly by select intestinal bacteria. For example, Lactobacillus rhamnosus has been
shown to decrease TNFα production in LPS-activated macrophages in a contactindependent manner, a phenomenon that is likely important for controlling pathogenic,
proinflammatory immune responses (Iwasaki 2007, Pena, Versalovic 2003). Indeed,
Crohn’s disease patients were found to have higher numbers of intestinal macrophages
that expressed the innate-immune receptor CD14 and produce larger amounts of
proinflammatory cytokines as compared to healthy controls (Kamada et al. 2008). These
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cells expressed both macrophage (CD14, CD33, CD68) and DC (CD205, CD209)
markers and evoked stronger TH1 and TH17 cell differentiation than non-CD14
expressing macrophages suggesting that intestinal APCs that lack tolerogenic properties
can contribute to inflammatory disease (Kamada et al. 2009). In summary, maintenance
of tolerogenic properties of antigen presenting cells may be in part mediated by
interactions with commensal populations.

1.5.4 The influence of commensal-derived signals on lymphoid-tissue inducer and
natural killer cell differentiation and function
Lymphoid-tissue inducer (LTi) cells are RORγt+ IL-7Rα+ innate leukocytes that induce
lymph node development in the embryo through the production of lymphotoxin-β and
TNF and the recruitment of circulating LTi cells, their precursors, and more mature
lymphocytes (Colonna 2009). In adult mice, clusters of LTi cells are found in the
cryptopatches of the small intestine, and in secondary lymphoid organs such as the
spleen, where they participate in maintaining local lymphoid tissue anatomy (Colonna
2009). LTi cells are an innate source of IL-17 and IL-22 (an IL-10-family member that
contributes to epithelial-cell resistance and repair by inducing the production of
antimicrobial proteins such as β-defensins, RegIIIγ, S100 calcium-binding proteins, and
regenerating gene family proteins) (Takatori et al. 2009). Recently, CD4+ LTi cells were
shown to promote innate immunity to Citrobacter rodentium infection in an IL-23dependent mechanism and IL-23-responsive innate lymphoid cells were found to be
increased in inflammatory bowel disease implicating these cell types as important
contributors to human disease (Geremia et al. 2011, Sonnenberg et al. 2011). The
finding that lymphoid follicles are underdeveloped in germ-free mice has led some to
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speculate that LTi cells might be regulated by bacterial signals; however, one study to
date indicated that LTi cell numbers and function were similar in the mucosa of germfree as compared to conventional mice (Sanos et al. 2008).
Nevertheless, an intriguing connection exists between LTi cells and another cell
population known to be regulated by intestinal bacteria; namely, IL-22 producing
intestinal Natural Killer (NK)-like (NK-22) cells. Intestinal NK-22 cells are found in the
cryptopatches and lamina propria of adult mice where they are an important innate
source of IL-22 (Sanos et al. 2008, Cella et al. 2008, Satoh-Takayama et al. 2008, Luci
et al. 2009). Production of IL-22 by mucosal NK-22 cells may contribute to defense
against the extracellular enteric pathogen Citrobacter rodentium as the partial depletion
of mucosal NK-22 cells increased the mortality of infected mice (Cella et al. 2008, SatohTakayama et al. 2008). In addition, NK-22 cells have been shown to mediate protection
from experimental colitis supporting the hypothesis that these cells are involved in
defense against assaults to the enteric mucosa (Zenewicz et al. 2008).
LTi cells can differentiate into NK-like cells in vitro that express both LTi and NK
cell receptors (Mebius, Rennert & Weissman 1997) (reviewed in (Vivier, Spits & Cupedo
2009)). Additionally, human fetal LTi cells gave rise to NKp44+ cells that produced IL-17
and IL-22 in vitro (Cupedo et al. 2009). However, questions remain as to the relationship
between LTi cells and NK-22 cells in vivo as LTi cells develop independently of
commensal-derived signals but are required for lymphoid tissue development, while
lymphoid tissue development and the development of IL-22 producing intestinal NK cells
are both dependent on bacterial signals. The dependence of NK-22 cells on RORγt
expression further suggests that LTi cells and NK-22 cells may be related either
developmentally or functionally (Colonna 2009). Intestinal LTi cells and NK-22 cells both
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upregulate IL-22 production shortly after birth suggesting that colonization of the
intestine drives IL-22 production by these cell types in humans and mice (Sanos et al.
2008, Satoh-Takayama et al. 2008). Finally, absolute and relative numbers of NK-22
cells were reduced in germ-free as compared to conventionally-reared mice (Sanos et
al. 2008) further implicating signals from intestinal bacteria in NK-22 cell development.
These findings suggest that signals from intestinal bacteria promote mucosal
homeostasis in part by promoting the induction of IL-22 producing innate leukocytes.

1.5.5 The influence of commensal-derived signals on B cell differentiation and
function
A typical intestinal lymphoid follicle has a germinal center, a B lymphocyte–rich
peripheral zone, and a dome-shaped ―corona‖ containing B cells, CD4+ T cells, dendritic
cells, and macrophages (Brandtzaeg et al. 1988) (Figure 4). APCs immediately under
the epithelium are presumably active in uptake and killing of incoming pathogens as well
as in processing, presentation, and perhaps storage of antigens. There is an intimate
relationship between intestinal communities and B lymphocytes that reside in intestinal
lymphoid structures. As discussed previously, the first immunological response to
bacterial signals during colonization is IgA production and secretion into the intestinal
lumen (Macpherson 2006, Klaasen et al. 1993). In fact, the large majority of B cells in
the intestine are immunoglobulin A (IgA)-producing plasma cells which produce and
secrete IgA into the intestinal lumen at an estimated rate of 0.8 grams per meter of
intestine per day (Brandtzaeg et al. 1989, Goldblum, Hannson & Brandtzaeg 1996). This
secretory immune response, which is characterized by class-switching of B cells from
IgM to IgA production, is orchestrated through an intimate functional relationship
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between secretory epithelia and local plasma cells and is mediated by TLRs through Tcell dependent and independent mechanisms (Macpherson et al. 2000, He et al. 2007).
For example, intestinal bacteria trigger T cell-independent IgA class switching in B cells
through IEC secretion of cytokines including APRIL (He et al. 2007, Xu et al. 2007). In
addition, IEC-derived TSLP and IL-10, produced in response to bacterial signals, may
orchestrate local B cell responses (He et al. 2007, Xu et al. 2007, Astrakhan et al. 2007).
Secretory IgA creates a first-line defense against mucosal compromise that is lost during
IBD (Lodes et al. 2004, Brandtzaeg, Carlsen & Halstensen 2006). Together, these
findings implicate early recognition of bacterial-derived signals and the subsequent
modulation of B cell responses as important processes that promote normal mucosal
homeostasis.
There are several findings in germ-free mice that support a role for bacterial
signals in B cell development. There are reduced numbers of plasma cells in the germfree small intestine which correlates with reduced IgA production (Glaister 1973, Crabbe
et al. 1970). Systemically, there are also reduced numbers of germinal centers and
plasma cells in germ-free mice which correlate with reduced systemic immunoglobulin
levels (Hooijkaas et al. 1984, Gustafsson, Laurell 1959, Gordon, Brauckner-Kardoss
1961, Wagner, Wostmann 1961, Ikari 1964, Sell 1964). Germ-free mice also show
reduced antigen-specific immunoglobulins to some antigens (DNP-BSA, E. coli) but not
others (RBC, phosphorylcholine, DNP-lys-Ficoll) (Horowitz et al. 1964, Ohwaki et al.
1977, Etlinger, Heusser 1986). In general, these intestinal and systemic immunoglobulin
defects are corrected upon conventionalization of germ-free animals suggesting that
these defects are not developmental and that commensal-derived signals actively
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maintain these aspects of B cell physiology (Crabbe et al. 1970, Gustafsson, Laurell
1959, Wagner, Wostmann 1961, Moreau et al. 1978).
One exception to the trend of reduced immunoglobulin levels is IgE. There are
increased IgE bearing B cells in the Peyer’s patches of germ-free mice as well as
increased serum IgE responses upon antibiotic treatment of conventionally-reared mice
(Bashir et al. 2004, Durkin, Bazin & Waksman 1981). The IgE found in germ-free mice is
composed of natural specificities and induced by a mechanism independent of MHC
class II (MHC II) cognate help (McCoy et al. 2006). These findings suggest that in
general, microbial signals act as an adjuvant to immunoglobulin responses with the
exception of allergic IgE responses, where commensal-derived signals may play an
immunoregulatory role.

1.5.6 The influence of commensal-derived signals on CD8+ cytotoxic T cell
differentiation and function
The intestinal mucosa of conventionally-reared animals normally contains a large
population of resident T lymphocytes.

In the conventionally-reared mouse intestine,

CD4+ T cells are found primarily in the lamina propria while CD8+ T cells dominate in the
intraepithelial compartment (Jabri, Ebert 2007). The development or homeostasis of
CD8+ IELs is dependent on bacterial signals as MyD88-deficient and germ-free mice
display reduced CD8+ T cell numbers the IEL compartment of the small intestine
(Imaoka et al. 1996, Kawaguchi-Miyashita et al. 1996, Yu et al. 2006). Cytotoxic activity
of IELs is impaired in both germ-free and antibiotic-treated mice, a phenotype that can
be reversed through the administration of the TLR4 ligand LPS (Kawaguchi-Miyashita et
al. 1996, Paulos et al. 2007). In germ-free mice, this cytotoxic defect was isolated to αβ
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TCR-bearing IELs while the number and cytotoxicity of γδ TCR-bearing IELs was
comparable between germ-free and conventionally-reared mice (Kawaguchi-Miyashita et
al. 1996). These defects may be in part due to impaired clonal expansions of CD8αβ +
and CD8αα+ IELs (Helgeland et al. 2004).
The systemic distribution of CD8+ T cells is also dependent on bacterial signals.
Restricted-flora mice have a selective reduction in systemic plasmacytoid dendritic cells
as a result of enhanced cytotoxic T lymphocyte activity that is not observed in germ-free
mice (Fujiwara et al. 2008). Additionally, the liver is a site of activated CD8+ T cell
sequestering and subsequent apoptosis during systemic immune responses, a
phenomenon that is dependent on TLR4 ligands such as endotoxin from intestinal
bacteria (John, Crispe 2005). Finally, animals colonized with nonpathogenic Clostridium
sp. have reduced numbers of naïve, splenic CD8+ lymphocytes as compared to
conventionally-reared controls suggesting that signals from intestinal bacteria play an
active role in CD8+ lymphocyte regulation. Some of these effects may be a result of a
lack of MyD88-dependent signaling as CD8-intrinsic MyD88-dependent signaling is
important for CD8+ T cell survival and expansion (Huang et al. 2005, Rahman et al.
2008).
Though likely influenced by multiple immune cells in addition to CD8+ cytotoxic T
cells, microbial stimulation can also result in tumorigenesis under some conditions. The
first observation that microbial signals could influence tumor immunity came in the 18th
century when Deidier reported a correlation between patient infection and the remission
of malignant disease, a finding that eventually led to the use of LPS to treat primarily
inoperable sarcoma with a cure rate of better than 10% (Garay et al. 2007). These early
findings indicate that microbial signaling through TLRs is important for initiating or
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sustaining anti-tumor immune responses (reviewed in (Rakoff-Nahoum, Medzhitov
2009)). This hypothesis has now been supported by several studies in animal models
and patients (Krieg 2007, Paulos et al. 2007, Apetoh et al. 2007, Yusuf et al. 2008).
Animal models have provided additional insights into how commensal-derived
signals influence tumor immunity. MyD88-deficient mice are protected against the
development of spontaneous intestinal tumors in a model of familial associated
polyposis (FAP) and germ-free animals have reduced intestinal tumorigenesis as
compared to conventionally-reared animals following the same protocol of colorectal
cancer induction (Rakoff-Nahoum, Medzhitov 2007, Vannucci et al. 2008). Similarly,
hepatocellular carcinoma, the most common liver cancer, occurs mainly in males. This
gender disparity is also seen in mice given the chemical carcinogen diethylnitrosamine
and was shown to be dependent on MyD88-mediated increases in serum interleukin-6
(IL-6) (Naugler et al. 2007). In humans, associations between intestinal bacteria and
cancer risk have been explored and studies were performed to identify fecal bacterial
communities associated with high colorectal cancer risk though they failed to provide
conclusive results (Moore, Moore 1995, Benno et al. 1986, Finegold et al. 1975, Huycke,
Gaskins 2004). In summary, clarifying the influence of bacterial signals in establishing
normal cytotoxic immune capacities has led to exciting therapeutic possibilities but more
research is needed to fully understand the role that signals from intestinal bacteria play
in tumor-genesis and control.
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1.6 The influence of commensal bacterial-derived signals on CD4+ T
helper cell responses
1.6.1 CD4+ T helper cells
Protective adaptive immunity in mammals is dependent on the development and
activation of antigen-specific CD4+ T cells by innate accessory cells such as DCs and
macrophages. Innate accessory cells signal in cis and trans via the T cell receptors, costimulatory molecules, Notch signaling and autocrine and paracrine cytokine signaling to
specify the optimal helper T cell fate to combat the specific pathogen (Zhu, Yamane &
Paul 2010). Helper T cells subsequently mobilize distinct innate and adaptive effector
cells, as well as induce characteristic changes in non-immune cell types, important for
host defense. T cell subsets are defined as T helper type (TH) 1, TH2, TH17 and
regulatory T cells (Treg) based on their unique cytokine production profiles, transcription
factor expression profiles and effector functions. In this section I discuss the influence of
commensal bacterial-derived signals on the development and function of the TH subsets.

1.6.2 The influence of commensal-derived signals on T helper 17 and regulatory T
cell responses
The differentiation of TH17 cells is dependent on the retinoic acid-related orphan receptor
(RORγt), requires TGF-β and IL-6 or IL-21, and relies on IL-23 for TH17 cell maturation
and survival (Korn et al. 2009). In the steady state, IL-17–producing cells are present in
high numbers in lamina propria of the small intestine and the TH17-related cytokines IL22 and IL-17 play a role in host protection against extracellular pathogens (Kastelein,
Hunter & Cua 2007, Dong 2008, Ivanov et al. 2008). Conventionally-reared animals
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have TLR-independent ―spontaneous‖ IL-17 production in the lamina propria of their
small intestine (Ivanov et al. 2008). Spontaneous IL-17 production was absent in germfree animals, suggesting that intestinal bacteria signal through a TLR-independent
mechanism to promote TH17 cell development (Ivanov et al. 2008). One mechanism by
which intestinal bacteria may regulate TH17 cell development independent of TLR
signaling is through the production of other bioactive molecules such as metabolites
(discussed above). Indeed, ATP has been shown to stimulate LP APCs to produce IL-6,
IL-23, and TGF-β, resulting in TH17 cell differentiation (Atarashi et al. 2008).
While TH17 cells are reduced in the small intestine of germ-free mice, more TH17
cells have been observed in the large intestine of germ-free as compared to
conventionally-reared mice (Zaph et al. 2008). In the large intestine, bacterial signals
regulate TH17 cell development through bacterial-dependent production of the IL-17
family cytokine IL-25 (IL-17E), which down regulates IL-17 production through the
inhibition of IL-23 production by lamina propria macrophages (Zaph et al. 2008). These
findings suggest that regulation of TH17 cell differentiation by commensal-derived signals
is dependent on anatomical location along the intestine. Indeed, the small and large
intestines are microbiologically and immunologically distinct sites. As discussed
previously, there are site specific differences in intestinal bacterial communities along
the length of the intestine. In addition, there are more intra-epithelial lymphocytes (IELs)
and lamina-propria lymphocytes (LPLs) per epithelial cell in the small intestine, and the
lymphocyte composition and migration to the small versus large intestine is differentially
regulated (Ivanov et al. 2008, Cheroutre 2004). These fundamental differences may
underlie differential regulation of TH17 cells in distinct anatomical sites.
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Studies in antibiotic treated mice mirror those from germ-free mice and support a
role for bacterial signals in the regulation of TH17 cell homeostasis. For example, mice
treated with vancomycin have fewer TH17 CD4+ T cells in the LP of the small intestine
(Atarashi et al. 2008, Ivanov et al. 2008, Niess et al. 2008). Additionally, TH17 cell
differentiation in the lamina propria of the small intestine has been shown to require
specific intestinal bacteria, specifically, cytophaga-flavobacter-bacteroidetes (CFB)
bacteria (Ivanov et al. 2008). This induction of TH17 cells was independent of TLR
signaling, IL-21, or IL-23, but required TGFβ activation suggesting that specific intestinal
bacteria regulates the TH17/Treg balance in the mammalian intestine.
An intimate relationship exists in the intestinal mucosa between proinflammatory
TH17 cells and CD4+ regulatory T cells that play an important role in controlling T H17 cell
responses (Belkaid, Tarbell 2009). Tregs are characterized as CD4+ CD25+ cells that
express the forkhead box P3 transcription factor (FoxP3) and have been shown to
suppress proliferation of effector T cells in vitro and to protect from autoimmune and
other inflammatory diseases in several animal models. For example, mice carrying a
loss-of-function mutation of FoxP3 completely lack Tregs and develop lethal
autoimmune disease while Lactobacillus and Bifidobacterium strains have been shown
to cause expansion of Tregs in the intestinal intraepithelial compartment and protect
against experimental colitis (Brunkow et al. 2001, Roselli et al. 2009). These findings
identify Foxp3 as a master regulator of Treg differentiation and function and identify
Tregs as an important regulatory cell type that contributes to intestinal and systemic
immune homeostasis.
There are differing reports of the influence of bacterial signals on Treg
development and function. Consist with studies that showed reduced FoxP3 mRNA in
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CD4+ T cells from mLNs of germ-free mice, early studies in germ-free animals showed a
selective reduction in the percentage of FoxP3+CD4+CD25+ T cells in the mLN of germfree mice (Strauch et al. 2005, Ostman et al. 2006). In addition to reduced frequencies,
it has been reported that Tregs from the mLN of germ-free animals did not suppress
CD4+ T cell proliferation in vitro as well as Tregs from conventionally-reared animals
(Ishikawa et al. 2008). Furthermore, Tregs from the mLN of germ-free mice produced
less IL-10 and did not protect as well against disease in a transfer model of experimental
colitis as compared to Tregs from conventionally-reared animals (Strauch et al. 2005).
Recent studies have identified Clostridium species as important inducers of colonic
regulatory T cells suggesting that specific commensal-derived signals are important for
maintenance of this cell population (Atarashi et al. 2011). Others have shown that local
and systemic Treg populations seem to be similar between conventionally-reared mice
and mice with reduced commensal stimulation (Zaph et al. 2008, Ichinohe et al. 2011).
Together, these results suggest that signals from intestinal bacteria are important for
normal development and maintenance of Treg numbers and function in intestinal
tissues.
However, there seem to be different effects of bacterial-derived signals on other
Treg populations. One study reported no change in the frequency of lamina propria
CD4+FoxP3+ T cells from the colon of germ-free animals while another reported
increased percentages of CD4+FoxP3+ in the small intestine (Zaph et al. 2008, Ivanov et
al. 2008). These differing results could be due sampling Treg cell subsets from different
anatomical locations (mLN vs. intestine). Additionally, these differences could be due to
experimental methods, animal housing, diet, non-bacterial microbial stimulation, or Treg
identification methods employed.
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1.6.3 The influence of commensal-derived signals on the TH1/TH2 cell balance
In humans, as in mice, two distinct patterns of cytokine secretion have been defined
among CD4+ helper T-cell clones; type 1 helper type (TH) 1 cells, but not TH2 cells,
produce IL-2, IFNγ, and TNFα, while TH2, but not TH1, cells produce IL-4, IL-5, IL-9 and
IL-13 but not IL-2 or IFNγ (reviewed in (Abbas, Murphy & Sher 1996)). These distinct
immune responses are important for protective responses to distinct infectious agents;
Th1 cell responses are protective against bacterial and protozoan infections while T H2
cell responses act in resistance to helminths and ectoparasites.
The influence of intestinal bacteria on TH2 cytokine-dependent inflammation has
been of particular interest of late given recent epidemiological findings that antibiotic use
in children results in significantly increased risk of developing allergic disease (Penders
et al. 2007, Marra et al. 2009, Kummeling et al. 2007). There is also a strong
experimental literature correlating states of reduced commensal stimulation with
increased TH2 cytokine-dependent inflammation. For example, germ-free mice have
impaired oral tolerance and increased levels of allergen-specific IgE compared to
conventionally-reared mice (Sudo et al. 1997). TLR4 signaling is important for
commensal bacterial-derived signals to promote oral tolerance as TLR4 deficient mice
display similar levels of food allergy compared to mice treated with oral antibiotics
(Bashir et al. 2004). Commensal bacterial-derived signals also seem to limit disease in
models of allergic asthma. Antibiotic treatment resulted in the selective outgrowth of
fungal microbes in the intestine and worse disease outcomes in an IL-13-dependent
mechanism (Noverr et al. 2005). In some cases specific bacterial species have been
shown to influence the development of TH2 cell responses. For example, treating
animals with antibiotics during infancy promoted a shift in the T H1/TH2 balance towards a
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TH2-dominant immunity, and this effect could be reduced by oral inoculation of mice with
Enterococcus faecalis or Lactobacillus acidophilus (Oyama et al. 2001, Sudo et al.
2002). Consistent with commensal-derived signals promoting TH1 cell environments,
optimal induction of TH1 cell development in vitro by DCs required TLR2 signaling (Wang
et al. 2006) and commensal-derived signals acts as adjuvants to promote immunity to
the protozoan parasite Toxoplasma gondii (Benson et al. 2009). Additionally, there is
evidence for DC-dependent CD4+ TH1 cell responses to commensal bacteria in normal
human intestinal lamina propria (Howe et al. 2009). Despite these associations, the
mechanisms by which the innate immune system recognizes commensal-bacterial
derived signals and influences the development of TH2 cytokine-dependent allergic
inflammation are not well understood.
As discussed previously, DCs recognize commensal bacterial-derived signals to
modulate subsequent adaptive T cell responses (Medzhitov 2007, Takenaka et al.
2007). However, DCs have recently been shown to be insufficient to prime optimal TH2
cell responses in select cases, implicating other innate immune cells in this role
(Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). In addition to their wellestablished roles as innate effector cells, basophils have recently been shown to
function as accessory cells by providing early sources of IL-4 and contributing to the
initiation of CD4+ TH2 cell responses (Gessner, Mohrs & Mohrs 2005, Mohrs et al. 2005,
Min et al. 2004). These findings implicate regulation of innate granulocyte populations as
a potential mechanism by which commensal-derived signals may limit TH2 cytokinedependent inflammation. The following section reviews basophil development and
effector functions as well as the recently appreciate roles for basophils in contributing to
the development of optimal TH2 cell responses.
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1.7 Basophils and the initiation and propagation of Type 2 cytokinedependent allergic inflammation
Discovered in 1897, basophils are the least abundant granulocyte population making up
less than 1% of peripheral blood leukocytes. Originally, basophils were thought to be
redundant to mast cells as they also bind immunoglobulin (Ig)E and release histamine
upon activation (Ishizaka et al. 1972). However, subsequent comparisons of basophils
and mast cells revealed that these two granulocytes are distinct and differ in many
aspects including their morphology, expression of surface markers, factors required for
growth and differentiation, activation and signal transduction pathways and release of
inflammatory mediators (MacGlashan et al. 1983, Siracusa et al. 2010). This section will
discuss classical roles for basophils as key effector cells recruited to sites of tissue
inflammation and the newly identified roles for basophils as innate cells that initiate and
propagate optimal allergic TH2 cell responses.

1.7.1 Basophil development and effector functions
Basophils develop from bone marrow resident granulocyte-monocyte precursor cells
(GMPs) which also give rise to the eosinophil and mast cell lineages (Arinobu et al.
2005). Two basophil precursor cell types have been identified that reportedly give rise to
mature basophils. The basophil precursor (BaP) is a bone marrow-resident population
that exits the bone marrow upon differentiation into a mature basophil while the spleenresident basophil-mast cell precursor (BMCP) gives rise to both basophil and mast cell
populations (Iwasaki, Akashi 2007). Expression of the transcriptions factors GATA-2 and
CCATT enhancer-binding protein C/EBPα are important for basophil development
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(Iwasaki, Akashi 2007) along with expression of IL-4 and IL-13 transcripts (Gessner,
Mohrs & Mohrs 2005). Unlike mast cells, which are not considered mature until they
enter a peripheral tissues site, basophils exit the bone marrow with a mature phenotype
(Galli 2000) and are only thought to survive between 60-70 hours (Iwasaki, Akashi 2007,
Mellblom 1980, Ohnmacht, Voehringer 2009). As such, circulating basophil populations
are likely continuously replenished by precursor populations (Ohnmacht, Voehringer
2009).
Classically, basophils are recognized as innate effector cells that are recruited to
sites of tissue inflammation upon activation. One of the primary routes of basophil
activation is crosslinking of immunoglobulins bound to the cell surface. Basophils
express the high affinity IgE receptor (εεR1α), which in turn binds natural and antigenspecific IgE from the serum. Upon cross-linking of FcεRIα, basophils release multiple
signaling molecules including histamine, leukotrienes, cytokines and chemokines that
contribute, along with mast cells, to the clinical sequelae of immediate hypersensitivity
reactions (Schroeder 2009). Basophils also express the IgG receptor FcγR and have
been shown to be the major cell type responsible for some immunoglobulin-G-mediated
immediate hypersensitivity reactions in some settings (Tsujimura et al. 2008, Ohnmacht
et al. 2010). In addition to immediate hypersensitivity, basophils have been shown to
contribute to chronic IgE-mediated allergic inflammation in mice (Ohnmacht et al. 2010,
Obata et al. 2007). In this model, basophils were not required for the immediate- or latephase responses to subcutaneous antigen administration, but were necessary for the
subsequent edema and recruitment of eosinophilic and neutrophilic infiltrates to the site
of antigen injection. These findings suggest that basophils mediate the recruitment of
other innate effector cells to inflammatory sites. Finally, basophils have been shown to
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be activated by IgD, a class of antibody the function of which remains unclear. Produced
in the upper respiratory tract of mammals and implicated in immunity to respiratory
pathogens, IgD-mediated activation of basophils resulted in the production of IL-4, antimicrobial peptides, B cell-activating factor and the induction of class switching of B cells
to IgM, IgD and IgA isotypes (Chen et al. 2009). Together, these findings identify several
pathways of basophil activation by immunoglobulins that result in diverse effector
functions.
Other avenues to basophil activation include cytokines, proteases, TLRs,
complement proteins and super-antigens. IL-3 is a T cell-derived cytokine and a potent
regulator of basophil responses. Though basophils represent a relatively small
proportion of circulating immune cells in the steady-state, circulating basophil
populations can expand dramatically in response to IL-3 (Lantz et al. 1998, Lantz et al.
2008, Shen et al. 2008, Ohmori et al. 2009). IL-3 has been shown to both increase
basophil survival and act on bone marrow-resident basophil precursors to increase the
population of circulating basophils (Lantz et al. 1998, Lantz et al. 2008, Ohmori et al.
2009). Additionally, IL-3 augments IL-4 and IL-13 production by purified human
basophils following activation by IgE (Gibbs et al. 1996, MacGlashan et al. 1994).
However, while these studies identify an important role for IL-3 in mediating basophil
responses, IL-3-IL-3R signaling is not absolutely essential for basophil development or
survival as IL-3 receptor-deficient mice display near normal circulating basophil
frequencies (Lantz et al. 1998). Consistent with other cytokines or molecules supporting
steady-state basophil homeostasis, IL-18 and IL-33, which are produced by innate
immune cells including macrophages and epithelial cells in response to allergic and
parasitic stimuli (Kroeger, Sullivan & Locksley 2009, Pecaric-Petkovic et al. 2009), have
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been shown to enhance basophil survival and augment basophil cytokine production
(Kroeger, Sullivan & Locksley 2009, Yoshimoto et al. 1999).
Another mechanism of basophil activation is via proteases that are thought to
directly activate basophils independently of immunoglobulins or cytokines. This
mechanism of basophil activation presumably evolved to respond to proteases secreted
from helminth parasites, but plays an active role in basophil responses to allergic stimuli.
For example, papain, a cysteine protease and potent allergen associated with
occupational allergy in humans (Novey et al. 1979) and TH2 cell responses in mice
(Sokol et al. 2008), is capable of directly inducing IL-4 and IL-6 production from bone
marrow-derived murine basophils (Sokol et al. 2008). Additionally, the house dust mite
(HDM) protease Derp1 induces production of IL-4, IL-5 and IL-13 from a human basophil
cell line (Phillips et al. 2003). In both the case of papain and Derp1, activation of
basophils is dependent on protease activity (Sokol et al. 2008, Phillips et al. 2003), and
in the case of Derp1, may result from functional mimicry of the TLR4 receptor complex
(Trompette et al. 2009). Consistent with basophils contributing to HDM-induced allergic
inflammation, depletion of basophils via treatment with a monoclonal antibody targeting
CD200R resulted in reduced HDM-elicited TH2 cytokine-responses (Hammad et al.
2010). One mechanism by which basophils may sense protease activity is via proteaseactivated receptors (PARs), a family of receptors known to activate innate and adaptive
immune cells in response to infectious or allergic stimuli (Shpacovitch et al. 2008).
However, PAR expression has not been detected in murine basophils implicating other
receptors or molecular mechanisms in the activation of basophils by proteases (Falcone,
Morroll & Gibbs 2005).
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Finally, additional molecular signals known to influence innate basophil response
include TLR ligands, complement proteins and super-antigens. While basophils are
reported to express TLR1, TLR2, TLR4, TLR6 and TLR9, only TLR2 ligands have been
shown to activate basophils directly (Siracusa et al. 2010, Sabroe et al. 2002, Bieneman
et al. 2005, Komiya et al. 2006). Specifically, lipopolysaccharide treatment of purified
human basophils resulted in their production of IL-4 and IL-13 (Sabroe et al. 2002,
Bieneman et al. 2005). Human basophils also express receptors to the complement
proteins CR1, CR3, CR4 and CD88 and produce histamine in response to C5a (Hook,
Siraganian & Wahl 1975, Siraganian, Hook 1976). Finally, direct, non-specific activation
of basophils by super-antigens has been reported. For example, the gp120 glycoprotein
of HIV interacts with the VH3 region of IgE to induce IL-4 and IL-13 production from
human basophils (Patella et al. 2000) while the IPSE/alpha-1 glycoprotein from
Schistosoma

mansoni

eggs

induces

IgE-dependent,

antigen-independent

IL-4

production by murine basophils in vivo (Schramm et al. 2007). Together, these findings
identify important roles for basophils as innate effector cell populations that contribute to
immunity to parasitic infections and pathology of inflammatory diseases.

1.7.2 Synergistic roles for basophils and dendritic cells in the initiation of TH2 cell
responses
As discussed previously, dendritic cells (DCs) are perhaps the most efficient initiators of
adaptive immune responses and represent an important link between the innate and
adaptive immune systems (Trombetta, Mellman 2005). Consistently, mouse models
indicate that DCs contribute to the development of TH2 cell-dependent immunity and
inflammation. For example, DCs exposed to S. mansoni egg antigen (SEA) preparations
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promote TH2 cell differentiation in vitro and in vivo (Marshall, Pearce 2008), an
immunologic outcome that may be mediated by low dose stimulation of the TCR
(Steinfelder et al. 2009). Another mechanism by which TH2 responses are initiated may
be through direct modulation of DC activity by helminth-derived signals. For example,
excretory-secretory products from Heligmosomoides polygyrus and Nippostrongylus
brasiliensis, but not T. muris, can directly suppress DC production of IL-12p40
(Massacand et al. 2009). Recently, loss-of-function studies have shown DC populations
to be critically important for the development of optimal T H2 cell responses to some
stimuli. For example, depletion of DCs early in the immune response against S. mansoni
resulted in impaired TH2 cell development and increased production of IFN-γ by CD4+ T
cells (Phythian-Adams et al. 2010). Additionally, DCs are sufficient to induce protective
immunity to T. muris when interferon γ is blocked with a neutralizing antibody (Perrigoue
et al. 2009). Finally, a FcεRIα-expressing inflammatory DC sub-type were found to be
necessary and sufficient for the induction of TH2 immunity and allergic airway disease
using two murine asthma models, while other innate immune cell types including
basophils played a supporting role (Hammad et al. 2010, van Rijt et al. 2005).
Despite findings that indicate that DCs are necessary for TH2 cell induction under
some conditions, there is a growing body of evidence suggesting that DCs, when acting
independently from other innate cell types, are not sufficient for the induction of optimal
TH2 cytokine responses. For example, restriction of MHCII expression to CD11c+ cells
was found to be insufficient for optimal induction of protective immunity to T. muris
(Perrigoue et al. 2009). Similarly, DCs were not required for TH2 cell induction in
response to papain while basophils were found to be critically required (Sokol et al.
2009). Together, these results suggest that cognate, MHCII-dependent interactions

54

between T cells and CD11c- cell populations contribute to the development of optimal
TH2 cell responses.
In addition to their well-established roles as late phase innate effector cells,
basophils have also recently been shown to function as important accessory cells by
providing early sources of IL-4 and contributing to the initiation and/or propagation of
CD4+ TH2 cell responses (Gessner, Mohrs & Mohrs 2005, Mohrs et al. 2005, Min et al.
2004). Human basophils can produce more IL-4 per cell than activated TH2 cells (Mitre
et al. 2004) and murine studies indicate that basophil-derived IL-4 contributes to TH2 cell
development in the presence of antigen and dendritic cells (Hida et al. 2005, Oh et al.
2007). Together, these findings identify basophils as an innate cell population that can
produce IL-4 and augment TH2 cell differentiation in vitro. In addition, studies in murine
disease models have identified a role for basophils in promoting TH2 cell responses in
vivo. For example, environments enriched for basophils, via continuous IL-3 treatment or
deficiency in the interferon regulatory factor 2, result in preferential differentiation of TH2
cells (Hida et al. 2005, Oh et al. 2007). Consistent with basophils influencing T cell
responses, IL-4 expressing basophils are recruited from the circulation to draining lymph
nodes in response to infectious (Perrigoue et al. 2009) or allergic stimuli (Sokol et al.
2008) where they augment TH2 cell differentiation. Critically, TH2 cell responses are
reduced upon basophil depletion in multiple allergy models including papain (Sokol et al.
2008) and house dust mite allergen (Hammad et al. 2010), indicating that basophils
contribute to the development of optimal TH2 cell responses in these settings.
Finally, in addition to being an innate source of IL-4, murine and human studies
have demonstrated that basophils express MHC class II, endocytose soluble antigen,
express MHC II and co-stimulatory molecules, and in select cases can act as antigen
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presenting cells that promote antigen-specific TH2 cell differentiation (Perrigoue et al.
2009, Sokol et al. 2009, Yoshimoto et al. 2009). Consistently, basophils have been
shown to promote TH2 cell differentiation in vitro and in vivo (Sokol et al. 2009,
Yoshimoto et al. 2009). Furthermore, adoptive-transfer of antigen-pulsed basophils into
MHC II-deficient hosts indicated that basophils were sufficient to promote antigenspecific TH2 cell differentiation (Yoshimoto et al. 2009). Finally, adoptive-transfer of
basophils increased TH2 cell differentiation and immunity to T. muris, as well as TH2 cell
responses to S. mansoni egg preparations in vivo (Siracusa et al. In Press, Perrigoue et
al. 2009). Together, these data indicate that in addition to providing innate IL-4 that
augments DC-dependent TH2 cell development, basophils can support the initiation or
propagation of antigen-specific TH2 cell responses in an MHC II-dependent manner.
These recently appreciated roles for basophils in augmenting TH2 cell responses and
TH2 cytokine-mediated allergic inflammation have led to corollary studies in humans and
models of human disease. For example, basophils were found to be activated by selfreactive IgE antibodies and recruited to lymph nodes where they promoted T H2 cell
differentiation in a model of lupus nephritis (Charles et al. 2010). Patients with systemic
lupus erythematous were found to have elevated self-reactive IgE levels and activated
basophils that express MHC II and were associated with disease activity and active
lupus nephritis (Charles et al. 2010). Together, these results identify basophils as an
innate granulocyte population that contributes to the development of optimal T H2
cytokine-dependent allergic inflammation and is correlated with human TH2 cytokinemediated diseases. However, the potential influence of commensal bacterial-derived
signals on these and other innate granulocytes known to contribute to allergic T H2 cell
responses is not characterized.
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Chapter 2: The influence of antibiotic treatment on
commensal bacterial communities of the intestine
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2.1 Abstract
Despite widespread use of antibiotics, few studies have measured their effects on the
burden or diversity of bacteria in the mammalian intestine. This chapter describes the
development of an oral antibiotic treatment protocol and the characterization of its
effects on murine intestinal bacterial communities. Antibiotic administration resulted in a
ten-fold reduction in the amount of intestinal bacteria present and sequencing of 16S
rDNA segments revealed significant temporal and spatial effects on luminal and
mucosal-associated communities including reductions in luminal Firmicutes and
mucosal-associated Lactobacillus species, and persistence of bacteria belonging to the
Bacteroidetes and Proteobacteria phyla. This comprehensive temporal and spatial
metagenomic analyses provides a resource and framework to test the influence of
bacterial communities in murine models of human disease.

2.2 Introduction
The human intestine is colonized by 100 trillion microorganisms belonging to each of the
three domains of life (Eckburg, Lepp & Relman 2003). Of these, bacteria are the most
abundant—the colon is home to approximately 1011 to 1014 bacterial cells per mL of stool
(Whitman, Coleman & Wiebe 1998) and has a diversity of at least 1000 species (Ley,
Peterson & Gordon 2006). Through recent advances in surveying non-culturable
intestinal communities using 16S ribosomal DNA (16S rDNA) sequencing (Pace, Olsen
& Woese 1986) and microarray-based methods, it has become clear that the major
bacterial phyla in the mammalian intestine include Bacteroidetes (Bacteroidetes class),
Firmicutes (Clostridia class), Proteobacteria (Alpha, Beta, Gamma, and Epsilon classes),
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Actinobacteria, and Fusobacteria (Palmer et al. 2007, Eckburg et al. 2005). Some
intestinal bacteria are mutualists that promote normal mammalian physiology including
proper digestion (Hooper, Midtvedt & Gordon 2002), metabolism (Backhed et al. 2004),
epithelial cell function (Artis 2008), angiogenesis (Stappenbeck, Hooper & Gordon
2002), enteric nerve function (Husebye, Hellstrom & Midtvedt 1994), and immune
system development (Hill, Artis 2010). While bacterial communities promote normal
immune homeostasis, patients with inflammatory bowel disease (IBD) (Frank et al. 2007)
and atopic allergies (Bjorksten et al. 2001) have altered intestinal communities,
indicating that microbial communities might influence the pathogenesis of these
diseases (Marra et al. 2009, Strober, Fuss & Blumberg 2002).
Antibiotic treatment has the adverse effect of altering intestinal microbial
communities (Hoban 2003) and antibiotic exposure is linked to increased risk of
Clostridium difficile colitis (De La Cochetiere et al. 2008) and asthma (Marra et al. 2009,
Kummeling et al. 2007, Wickens et al. 1999) in humans. In keeping with these findings,
antibiotic treatment in animal model systems has identified complex pro-inflammatory
and immunoregulatory roles for intestinal communities in modulating intestinal cytokine
responses (Zaph et al. 2008, Hall et al. 2008, Mazmanian, Round & Kasper 2008), in
altering resistance to enteric pathogens (Sekirov et al. 2008, Hall et al. 2008, Stecher et
al. 2007, Garner et al. 2009, Croswell et al. 2009), in maintaining mucosal homeostasis
(Rakoff-Nahoum et al. 2004, Kang et al. 2008), and in controlling allergic inflammation
(Bashir et al. 2004). However, while the use of oral broad-spectrum antibiotics in
humans and animal models is common, knowledge of how antibiotics influence intestinal
bacterial communities is limited.
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Previous studies using culture and fluorescence in situ hybridization based
methods have provided some insights into antibiotic effects on a limited subset of
intestinal bacteria (Sekirov et al. 2008, Miller, Bohnhoff 1963). More recently, molecular
based examination of antibiotic treatment in humans showed effects on intestinal
communities, but was confounded by inter-individual variability (Dethlefsen et al. 2008).
Animal models have proven well-suited for metagenomic studies because they allow for
control of host genetic background, feeding practices, and antibiotic administration. In
one such study of bacterial recovery after antibiotic perturbation, single-antibiotic effects
were characterized at the phylum level at a single time point and anatomic location
(Antonopoulos et al. 2009). Other groups have reported the general effects of oral
antibiotic treatment on intestinal bacteria, including significant changes to lactobacilli,
enterococci/group D streptococci, Firmicutes, Bacteroidales, or segmented filamentous
bacteria, depending on the specific antibiotic and treatment protocol (Sekirov et al. 2008,
Stecher et al. 2007, Garner et al. 2009, Croswell et al. 2009). However, the interpretation
of these studies is limited as in-depth temporal and spatial analysis of the effects of
antibiotic treatment on microbial communities was not undertaken.
In this chapter, we characterized the effects of two different antibiotic treatment
protocols on murine intestinal bacterial communities and immune cell homeostasis. We
found that published protocols involving administration of multiple antibiotics (ampicillin,
gentamicin, metronidazole, neomycin, and vancomycin) in drinking water altered
intestinal microbiota, but were complicated by the development of severe dehydration in
the host. For this reason, we developed an oral gavage-based protocol that facilitated
controlled antibiotic dosing without the development of dehydration. Using DNA barcoding and pyrosequencing of 16S rDNA gene segments, we examined temporal effects
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of antibiotics on bacterial communities and found significant reductions in the frequency
of bacteria belonging to the Firmicutes phylum and persistence of the Bacteroidetes and
Proteobacteria phyla over time. Additionally, we performed spatial analysis of luminal
and mucosal-associated bacterial communities following antibiotic treatment and found
significant effects in the cecum, proximal colon, and distal colon including reductions in
mucosal-associated Lactobacillus species.

2.3 Methods
2.3.1 Animals
Conventionally reared, six to eight week old female C57BL/6 mice were obtained from
Charles River Laboratory and maintained in a specific pathogen–free facility. Animals
were housed by litter and fed autoclaved LabDiet 5010 mouse chow (LabDiet,
Richmond, IN) and autoclaved water. Germ-free animals were maintained in plastic
isolator units and fed autoclaved LabDiet 5021 mouse chow (LabDiet, Richmond, IN)
and autoclaved water. Isolators were checked weekly and consistently cultured negative
for microbial contaminants. All experiments were approved by and performed following
the guidelines of the University of Pennsylvania Institutional Animal Care and Use
committee.

2.3.2 Antibiotic Treatment
For continuous antibiotic treatment, animals were provided with autoclaved drinking
water, or autoclaved drinking water supplemented with ampicillin (1 mg/mL), gentamicin
(1 mg/mL), metronidazole (1 mg/mL), neomycin (1 mg/mL), and vancomycin (0.5
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mg/mL). For antibiotic treatment by oral gavage, animals had access to autoclaved food
and water and were subjected to oral gavage daily for ten days with 200 μL of
autoclaved water or autoclaved water supplemented with ampicillin (1 mg/mL),
gentamicin (1 mg/mL), metronidazole (1 mg/mL), neomycin (1 mg/mL), and vancomycin
(0.5 mg/mL).

2.3.3 16S rDNA sample acquisition and quantification of 16S rDNA
Stool pellet, luminal content, and washed mucosal-associated tissue samples were
collected and total DNA was extracted using the QIAamp® DNA Stool Mini Kit (stool
pellet/luminal samples)(Qiagen, Inc., Valencia, CA) or the DNeasy Blood and Tissue Kit
(tissue samples)(Qiagen, Inc., Valencia, CA). Quantification of 16S rDNA was performed
by real-time RT-PCR using degenerate bacterial 16S rDNA specific primers (5’–
AGAGTTTGATCCTGGCTCAG-3’;forward), (5’-CTGCTGCCTYCCGTA-3’;reverse), (5'FAM-TA+ACA+CATG+CA+AGTC+GA-BHQ1-3'; probe; + precedes the position of LNA
base).

2.3.4 DNA manipulations
16S rRNA gene fragments were obtained as previously described (McKenna et al.
2008). Samples were amplified using 8 nucleotide-barcoded primer pairs (BSF8; 5´AGAGTTTGATCCTGGCTCAG-3´), (BSR357; 5´-CTGCTGCCTYCCGTA-3´). 50 μL
PCR reactions were carried out using the AmpliTaq System (Applied Biosystems, Inc.,
Foster City, CA) (Buffer II, 2 mM MgCl2, 200 μM each dNTP, 10 μM each primer, 0.1
mg/mL BSA, 100 ng (stool) or 500 ng (tissue) of template, 2.5 units polymerase). Cycle
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parameters: 1 minute 95° C, 20 cycles (stool pellet and luminal samples) or 25 cycles
(tissue samples) of 30 secs at 95° C, 30 secs at 56° C, and 90 secs at 72° C, final
extension at 72° C for 8 minutes. PCR products were gel purified using the QIAquick ®
Gel extraction kit (Qiagen, Inc., Valencia, CA). 100 ng of each amplicon was pooled and
subjected to pyrosequencing.

2.3.5 Bioinformatic analysis
Sequence quality was accessed and samples with >100 sequences were carried
through to subsequent analyses. Sequences were inserted into the 16S rRNA gene tree
(Hugenholtz 2002) using parsimony insertion implemented in ARB. The tree constructed
using ARB was used to carry out UniFrac analysis to compare global community
structure as described previously (Lozupone, Knight 2005, Lozupone, Hamady & Knight
2006, Lozupone et al. 2007). Taxonomic assignments for each sequence were obtained
using RDP Classifier (Wang et al. 2007).

2.3.6 Histology, stool protein extraction, western blot
At necropsy, cecal tissue sections were removed and fixed in 4% paraformaldehyde
(PFA) and paraffin-embedded. 5 μm sections were cut and stained with hematoxylin and
eosin (H&E). Crypt morphology was quantified using ―NIS Elements BR‖ imaging
software (Nikon, Melville, NY). Fecal protein isolation was performed as previously
described (Artis et al. 2004). Samples were equalized by protein content, analyzed by
SDS-PAGE, and immunoblotted for RELMβ using a polyclonal rabbit anti-murine RELMβ
antibody (PeproTech, Rocky Hill, NJ). Blots were visualized using ECLTM (Amersham,
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Piscataway, NJ) and band intensity was quantified using ―UN-SCAN-IT‖ (Silk Scientific,
Inc., Orem, UT).

2.3.7 Statistics
UniFrac analysis: Regression analysis was performed on day 0-9 stool pellet samples
from naïve or antibiotic-treated animals. Pyrosequencing analysis: The frequencies of
bacterial group compared using a Mann-Whitney test. Each mouse was treated as a
biological replicate.

2.4 Results
2.4.1 Administration of antibiotics in drinking water alters bacterial communities but
results in severe dehydration
Antibiotic treatment has been used extensively to probe the effects of microbial signals
in disease, including murine models of intestinal inflammation (Rakoff-Nahoum et al.
2004, Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008) and allergy (Bashir et al. 2004,
Noverr et al. 2004). However, to date there has been limited analysis of how oral
antibiotics specifically influence intestinal bacterial communities. We sought to
characterize the effects of published antibiotic treatment protocols on intestinal bacterial
communities through analysis of bacterial 16S rDNA compositions. Following published
protocols, conventionally reared animals were given access to autoclaved water or
autoclaved water containing ampicillin, gentamicin, metronidazole, neomycin, and
vancomycin (Sekirov et al. 2008, Bashir et al. 2004, Rakoff-Nahoum et al. 2004, Zaph et
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al. 2008, Hall et al. 2008, Kang et al. 2008). Stool pellets were collected at day 10 posttreatment initiation and total DNA was extracted for quantitative analysis of 16S
ribosomal DNA (16S rDNA) genes by real-time RT-PCR. We observed a greater than
two log reduction in bacterial 16S rDNA after ten days of antibiotic treatment as
compared to control-treated animals (Figure 5a).
To examine the effects of antibiotics on the composition of bacterial communities
in stool pellets, we used 454/Roche pyrosequencing of 16S rDNA segments and
determined taxonomic assignments for each sequence using RDP Classifier. Antibiotic
administration resulted in reduced frequencies of bacteria belonging to the Bacteroidetes
phylum (Bacteroidaceae family) and Firmicutes phylum (Lachnospiraceae family).
Antibiotic administration also resulted in increased frequencies of other members of the
Firmicutes phylum (Leuconostocaceae and Streptococcaceae families) as well as
members of the Proteobacteria phylum (Enterobacteriaceae and Moraxellaceae families)
(Figure 5b, H2O vs. ABX).
We next investigated the origin of the bacterial 16S rDNA present in stool pellets
after antibiotic treatment. To determine whether these sequences represented a living
community that persisted after antibiotic treatment, we analyzed stool pellets from germfree animals and found bacterial community sequences similar to those present in stool
pellets from antibiotic-treated animals (Figure 5b). We hypothesized that antibiotic
treatment reduced intestinal bacteria to levels at which residual DNA in autoclaved food
became the major contributor of 16S rDNA sequences. To test this, DNA was extracted
from sterile mouse chow and 16S communities were shown to be indistinguishable from
those found in stool pellets from antibiotic-treated or germ-free animals (Figure 5b)
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indicating that stool pellets from these animals were contaminated with bacterial 16S
rDNA normally present in autoclaved food.

Figure 5: Antibiotic delivery in drinking water modulates intestinal communities but results in
animal dehydration
(a) 16S rDNA gene copies as quantified by real-time RT-PCR from stool pellets collected from
naïve (H2O, n=5) or antibiotic-treated (ABX; n=5) animals (±S.E.M). (b) Family-level phylogenetic
classification of 16S rDNA frequencies in stool pellets collected from naïve animals (H2O; n=5),
antibiotic-treated animals (ABX; n=5), germ-free animals (GF; n=3), or autoclaved animal food
(Chow; n=3). (c) Weights of animals fed unsupplemented (H2O; n=4) or antibiotic-supplemented
(ABX; n=4) water (***P≤0.001; ±S.E.M.). Antibiotic-treated animals were switched to
unsupplemented water at day 14 (dashed line).

We further sought to investigate the effects of antibiotics on intestinal immune
homeostasis. Unfortunately, we found that animals fed antibiotics in drinking water
rapidly showed signs of dehydration including weight loss, decreased skin turgor, and
hard stools while animals fed autoclaved water showed no signs of dehydration (Figure
5c). Similar antibiotic treatment protocols without gentamicin or with added sweetener
also resulted in dehydration (data not shown). These data reveal an adverse effect of
antibiotic treatment that confounds the interpretation of the effects of antibiotics on
immune cell homeostasis (Guseinov, Guseinova 2008).
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2.4.2 Development of a new, broad-spectrum antibiotic treatment regimen that
prevents animal dehydration
We developed an alternative protocol in which animals were orally gavaged with
autoclaved water or autoclaved water containing ampicillin, gentamicin, metronidazole,
neomycin, and vancomycin once daily for ten days. Daily weights and stool pellet
samples were taken and animals were sacrificed on day 10 for histologic, microbiologic,
and immunologic analyses. Animals treated with antibiotics by oral gavage maintained
their body weight (Figure 6a) and displayed no signs of dehydration. Treated animals
also developed loose stools (data not shown) as seen with antibiotic treatment in human
patients (Rohde, Bartolini & Jones 2009).
To examine the effects of this treatment regimen on intestinal bacteria, 16S rDNA
copy number was quantified in stool pellet samples using real-time RT-PCR. We
observed an initial increase in 16S rDNA copies in stool pellets from antibiotic treated
animals at day one post treatment initiation suggesting a flushing of bacterial DNA into
the stool, likely representing dead bacteria (Figure 6b, day 1). After nine days, we
observed a ten-fold reduction in total 16S rDNA in stool pellets of treated animals
(Figure 6b) consistent with a reduction in total bacterial load.
We next undertook gross anatomic and histologic analyses of antibiotic-treated
animals. Treated animals displayed characteristic enlarged ceca, similar to those seen in
germ-free animals (Figure 6c) (Thompson, Trexler 1971), as well as expansion of the
lamina propria and enterocyte hyperplasia resulting in increased intestinal villus width
and length (Figure 6d,e). Further, examination of RELMβ, a protein secreted from
intestinal goblet cells in response to intestinal colonization (Wang et al. 2005), showed a
trend towards reduction at day one that reached statistical significance by day five (P ≤
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0.001) and day nine (P ≤ 0.005) post-treatment initiation (Figure 6f). Thus, antibiotic
treatment by oral gavage resulted in bacterial depletion without dehydration, and this
was accompanied by anatomic, histologic, and immunologic changes characteristic of
reduced microbial stimulation.

2.4.3 Antibiotic treatment results in two phases of bacterial community restructuring
The temporal effects of antibiotic treatment on bacterial communities were examined
using pyrosequencing of bacterial 16S rDNA gene segments. We analyzed 49,994
sequences from 144 samples representing stool pellet, luminal, and mucosal-associated
bacterial communities originating from the cecum, proximal large intestine, and distal
large intestine of nine animals (four naïve and five antibiotic-treated). To characterize the
global effects of antibiotic treatment on the full intestinal microbiome, bacterial
communities were compared in control-treated or antibiotic-treated animals by
quantifying similarities based on phylogenetic distances using UniFrac as described
previously (Lozupone, Knight 2005, Lozupone, Hamady & Knight 2006, Lozupone et al.
2007). UniFrac distances were calculated in two different ways, using only
presence/absence information (unweighted) or taking into account the abundance of
each bacterial lineage (weighted) and Principal Coordinate Analysis was used to cluster
communities along orthogonal axes of maximal variance.
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Figure 6: Antibiotic administration by gavage mimics molecular, anatomic, histologic, and
immunologic characteristics of reduced microbial stimulation without animal dehydration
(a) Weights of animals gavaged with unsupplemented (H2O; n=4) or antibiotic supplemented (ABX; n=5)
water (±S.E.M.). (b) 16S rDNA gene copies as quantified from stool pellets collected before (day 0) or over
the course of antibiotic treatment (days 1, and 9) (n=5; (±S.E.M.). (c) Cecal images from control-treated
(H2O), day 10 antibiotic-treated (ABX), or germ-free (GF) animals (bar, 1 cm). (d) Photomicrographs of
hematoxylin-and-eosin-stained cecal sections from control-treated (H2O), day 10 antibiotic-treated (ABX),
or germ-free (GF) animals showing expansion of the lamina propria and enterocyte hyperplasia in ceca
from antibiotic-treated and germ-free animals (bar, 50 µm). (e) Quantification of cecal villus length and
width from control-treated (H2O; n=4), day 10 antibiotic-treated (ABX; n=5), or germ-free (GF; n=3)
animals (***P≤0.001; ±S.E.M). (f) Quantification of RELMβ protein in stool pellets by western blot over
the course of antibiotic treatment (n=5) (**P≤0.01; ±S.E.M).
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In unweighted UniFrac analysis, the first coordinate separated the stool pellet,
luminal, and mucosal-associated samples on the basis of antibiotic treatment, and
explained 26.8% of the variance (Figure 7a). Weighted UniFrac analysis also separated
samples on the basis of antibiotic treatment, with 75.4% of the variance represented by
the first principal coordinate (Figure 7b). These findings indicated that antibiotic
treatment resulted in new luminal and mucosal-associated bacterial communities that
were distinct from those seen in control-treated animals both in the proportions of the
different groups and in the types of bacteria present. Treated samples grouped tightly in
our weighted analysis with respect to the second coordinate axis (Figure 7b, 14.1% of
group variance) indicating that intestinal communities in treated animals were more
similar than those existing prior to treatment.
To examine the temporal effects of antibiotic treatment analysis of stool pellets
was utilized. Stool pellet analysis is both non-invasive and representative of luminal
community composition (Eckburg et al. 2005), allowing for longitudinal analyses. We
found that samples from day zero and day one had distinct graphical locations in both
unweighted and weighted UniFrac analyses (Figure 7a,b). This finding indicated an
initial shift in community structure that occurred quickly after initiation of antibiotic
treatment. Furthermore, unweighted and weighted UniFrac analyses revealed that the
second and third coordinates, respectively, separated longitudinal pellet samples on the
basis of treatment day (Figure 7c,d) indicating a second, more gradual change in
community structure over time. This trend reached statistical significance in antibiotictreated (P ≤ 0.0001, unweighted and weighted) but not control-treated animals. In
summary, UniFrac analysis of bacterial communities from control-treated or antibiotic-
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treated animals revealed a dramatic shift in community structure that occurred quickly
after antibiotic initiation, followed by a more gradual alteration in community structure
over time.
Unweighted UniFrac

a
0.3

0.4

0.2

0.3
PCA2 14.1%

0.1
PCA2 5.6%

Weighted UniFrac

b

0.0
–0.1
–0.2

–0.3
–0.4

H2O ABX
Pellet
Luminal
Mucosal

–0.4 –0.3 –0.2 –0.1 0.0

0.1

0.2

H2O ABX
Pellet
Luminal
0.2
Mucosal
0.1
0.0
–0.1

–0.2
0.3

–0.3

–0.3 –0.2 –0.1

0.4

c
0.4

Pellets unweighted
treatment: H2O
treatment: ABX
= 0.1454
0.0661

= 0.6428
0.0001

0.2
0.1
0.0

–0.1
–0.2
–0.3

1 2 3 4 5 6 7 89 1 2 3 4 5 6 7 89
Day
Day 1
H2O
ABX

0.1

0.2

0.3

0.4

2

3

Pellets weighted
treatment: H2O
treatment: ABX

d

PCA3 3.2%

PCA2 7.3%

0.3

0.0

PCA1 - 75.4%

PCA1 - 26.8%

4

5

0.10
0.08
0.06
0.04
0.02
0.00
–0.02
–0.04
–0.06
–0.08
–0.10
–0.12

6

= 0.0106
0.6322

= 0.7347
0.0001

1 2 3 4 5 6 7 89 1 2 3 4 5 6 7 89
Day
7

8

9

Figure 7: UniFrac analysis of restructuring of bacterial communities over time
(a) Unweighted or (b) weighted UniFrac analysis of stool pellet, luminal content or mucosal-associated
samples from control- or antibiotic-treated animals. (c) Unweighted or (d) weighted UniFrac analysis of
stool pellet samples from control-treated (H2O; n=4) or antibiotic-treated (ABX; n=5) animals from day 1
to day 9 post-treatment initiation. Colored symbols represent treatment day, white squares represent
means, red line represents linear regression analysis (±S.E.M., significance determined by regression
analysis).
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2.4.4 Antibiotic treatment causes reductions in Firmicutes with the persistence of
Bacteroidetes and Proteobacteria phyla over time
Phylogenetic placements allow the identification of bacterial taxa affected by antibiotic
treatment. Temporal analysis of stool pellet samples revealed a significant shift in
community composition on day one post-antibiotic treatment initiation (Figure 8a,b) that
was not observed in control-treated animals (data not shown). The timing of this shift is
consistent with the flushing of 16S rDNA into stool observed during quantitative analysis
(Figure 6b, day 1) and the graphical separation between day zero and day one samples
from treated animals in UniFrac analyses (Figure 7a,b). These findings indicate that
even short antibiotic courses can result in dramatic alterations to intestinal bacterial
communities. Temporal analysis of stool pellet samples over the course of treatment
further revealed a gradual change in bacterial proportions over time (Figure 8a) that was
consistent with the gradual alteration in community structure observed by UniFrac
(Figure 7c,d).
After nine days of antibiotic treatment, there were several statistically significant
differences between stool pellets from antibiotic-treated and control-treated animals.
These included reductions in the Porphyromonadaceae family, Marinilabilia genus,
Bacteroidales order, Bacteroidetes phylum, Weissella genus, Butyrivibrio genus,
Lachnospiraceae incertae sedis genus, Lachnospiraceae family, Anaerotruncus genus,
Ruminococcaceae incertae sedis genus, Ruminococcaceae family, and TM7 genera
incertae sedis (P values listed in Figure 8b; groups significantly reduced shaded in red).
Upon antibiotic treatment, there were increases in the frequency of bacteria belonging to
the Bacteroides genus, Parabacteroides genus, Prevotella genus, Prevotellaceae family,
Xylanibacter genus, Erysipelotrichaceae incertae sedis, and Akkermansia genus (P
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values listed in Figure 8b; groups significantly increased shaded in green). We did not
detect any statistically significant differences in bacterial frequencies over the course of
treatment in stool pellets from control-treated animals (data not shown). In summary, we
found that antibiotic treatment caused significant changes in stool pellet bacterial
communities and that these changes occurred in at least two phases, one that occurred
immediately after initiating treatment and one that progressed over the course of
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Figure 8: Metagenomic analysis of restructuring of intestinal bacterial communities over time
(a) Genus-level phylogenetic classification of 16S rDNA frequencies in stool pellets collected from controltreated (H2O; n=4) or antibiotic-treated (ABX; n=5) animals from day 0 to day 9. (b) Average frequency of
bacterial groups before (antibiotic day 0) or during (antibiotic day 1 and 9) antibiotic treatment. MannWhitney P values of changes in group frequency with antibiotic treatment. Frequency reductions on
antibiotic treatment shown in red, increases shown in green, non-significant changes blank.
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2.4.5 Antibiotic treatment results in significant alterations to luminal and mucosalassociated bacterial communities along the length of the colon
Bacterial communities are distinct along the length of the intestinal tract (Eckburg et al.
2005), and between luminal and mucosal sites (Zoetendal et al. 2002). Therefore, we
analyzed the spatial effects of antibiotic treatment on luminal bacterial communities
longitudinally along the colon (cecum, proximal colon, distal colon) (Figure 9a). In the
lumen, antibiotic treatment was associated with lower frequencies of bacteria belonging
to the Porphyromonadaceae family, Alistipes genus, Marinilabilia genus, Rikenellaceae
family, Bacteroidales order, Bacteroidetes phylum, Mucispirillum genus, Butyrivibrio
genus, Coprococcus genus, Lachnospiraceae incertae sedis, Lachnospiraceae family,
Anaerotruncus genus, Faecalibacterium genus, Ruminococcaceae incertae sedis,
Ruminococcaceae family and Clostridiales order (P values listed in Figure 9b; groups
significantly reduced shaded in red). Antibiotic treatment also resulted in significant
increases in the frequency of bacteria belonging to the Bacteroides genus,
Parabacteroides genus, Prevotella genus, Xylanibacter genus, Burkholderiales order,
Enterobacter genus, and Akkermansia genus (P values listed in Figure 9b; groups
significantly increased shaded in green).
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Figure 9: Antibiotics modify luminal bacterial communities along the length of the colon
(a) Genus- level phylogenetic classification of 16S rDNA frequencies in luminal samples collected from control-treated (H2O; n=4) or
day 10 antibiotic-treated (ABX; n=5) animals from the cecum (Ce), proximal colon (Prox) or distal colon (Dist). (b) Average frequency
of bacterial groups in samples from control-treated (H2O; n=4) or antibiotic-treated (antibiotic day 10; n=5) animals. Mann-Whitney
P values of changes in group frequency with antibiotic treatment. Frequency reductions on antibiotic treatment shown in red,
increases shown in green, non-significant changes blank.

Comparison of naïve mucosal-associated bacterial communities to naïve luminal
communities revealed statistically higher frequencies of bacteria belonging to the
Mucispirillum genus (P ≤ 0.012) and Lactobacillus genus (P ≤ 0.001), and lower
frequencies of the Alistipes genus (P ≤ 0.017) (Figure 9a vs. Figure 10a). Upon
antibiotic treatment, there were significant reductions in the frequency of mucosalassociated bacteria belonging to the Marinilabilia genus, Rikenellaceae family,
Bacteroidales order, Bacteroidetes phylum, Mucispirillum genus, Lactobacillus genus,
Acetitomaculum genus, Bryantella genus, Butyrivibrio genus, Coprococcus genus,
Lachnospiraceae incertae sedis, Lachnospiraceae family, Anaerotruncus genus,
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Ruminococcaceae family, and the Clostridiales order as compared to samples from
control-treated animals (P values listed in Figure 10b; groups significantly reduced
shaded in red). Upon antibiotic treatment, there were also significant increases in the
frequency of mucosal-associated bacteria belonging to the Bacteroides genus,
Parabacteroides genus, Prevotella genus, Prevotellaceae family, Xylanibacter genus,
and the Burkholderiales order (P values listed in Figure 10b; groups significantly
increased shaded in green). We were unable to amplify enough sequences from
proximal colon mucosal-associated samples for statistical analysis. In summary,
phylogenetic analyses revealed significant changes to luminal and mucosal-associated
bacterial communities following antibiotic treatment.
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Figure 10: Antibiotics modify mucosal-associated bacterial communities along the length of
the colon
(a) Genus- level phylogenetic classification of 16S rDNA frequencies in mucosal-associated samples collected from control-treated
(H2O; n=4) or day 10 antibiotic-treated (ABX; n=5) animals from the cecum (Ce), proximal colon (Prox) or distal colon (Dist). (b)
Average frequency of bacterial groups in samples from control-treated (H2O; n=4) or antibiotic-treated (antibiotic day 10; n=5)
animals. Mann-Whitney P values of changes in group frequency with antibiotic treatment. Frequency reductions on antibiotic
treatment shown in red, increases shown in green, non-significant changes blank.
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2.5 Discussion
This chapter describes the development of an antibiotic treatment protocol that
significantly alters intestinal bacterial communities and immune cell homeostasis without
animal dehydration. Deep sequencing was employed to quantify temporal and spatial
antibiotic effects on intestinal bacterial communities and show significant changes in
several bacterial groups that correlate with altered cytokine production by CD4+ T
lymphocytes in intestinal-associated lymphoid tissues.
Animals were initially treated with antibiotics in drinking water in a similar manner
to previously published protocols (Sekirov et al. 2008, Bashir et al. 2004, RakoffNahoum et al. 2004, Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008). This treatment
protocol reduced intestinal bacteria to the extent that DNA from food composed the
majority of recovered 16S rDNA sequences. However, this protocol was associated with
animal dehydration that may complicate the interpretation of subsequent immunologic
studies (Guseinov, Guseinova 2008). These findings also highlight the presence of
sterile microbial-derived signals and emphasize the importance of controlling for DNA
contamination from food in future immunologic and metagenomic studies. As an
alternative, acute administration of broad-spectrum antibiotics by gavage was employed,
while allowing animal access to untreated drinking water; more closely mimicking
antibiotic administration in humans. Animals treated by gavage did not show signs of
dehydration and developed loose stools similar to known consequences of antibiotic
treatment in patients (Rohde, Bartolini & Jones 2009). Antibiotic treatment by oral
gavage reduced absolute bacterial numbers and mimicked anatomic, histologic, and
immunologic characteristics of reduced bacterial stimulation.
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Temporal and spatial analyses of antibiotic effects on bacterial communities were
carried out using pyrosequencing of bacterial 16S rDNA gene segments. UniFrac
analysis revealed that samples from antibiotic treated animals grouped separately from,
and clustered more tightly than, samples from control-treated animals indicating that
antibiotic treatment promoted a novel community structure that was more similar
between antibiotic-treated as compared to control-treated animals. Day one stool pellet
samples from treated animals grouped closely with later time points consistent with an
initial, fast phase of community alteration. This finding was emphasized in temporal
analysis of stool pellet bacterial frequencies during treatment and suggests that even
short exposure to oral antibiotics creates distinct intestinal bacterial communities.
UniFrac and frequency analyses of stool pellet communities over the course of antibiotic
treatment further revealed progressive alterations in community structure, indicating that
intestinal bacterial communities are continuously modified over the course of antibiotic
treatment.
The influence of antibiotic treatment by oral-gavage on stool bacterial
communities was noticeably different from that observed during antibiotic administration
in animal drinking water. For example, sequences from the Bacteroidetes group
represented a relatively small proportion of sequences recovered from mice treated
continuously with antibiotics while a higher proportion of Bacteroidetes sequences were
recovered from animals treated with antibiotics by gavage. These differences likely arise
due to differences in the duration of treatment (four weeks vs. ten days), in the method
of antibiotic administration (continuous vs. gavage), in animal hydration state
(physiologic vs. non-physiologic), and in the relative contribution that 16S rDNA from
food makes to measured bacterial frequencies (higher with more efficient microbial
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depletion). This finding highlights the importance of controlling for 16S rDNA in food in
future metagenomic studies.
Previous studies have shown that antibiotic-treated animals develop allergic
responses (Bashir et al. 2004) and antibiotic use in children is associated with increased
risk of developing asthma later in life (Marra et al. 2009). In addition, early colonization
with Bacteroides fragilis has been implicated as a risk factor for asthma development in
humans (Vael et al. 2008). As such, the effects of antibiotic treatment on members of the
Bacteroidies phylum were examined. Members of the Bacteroidies phylum, namely the
Bacteroidales order, represented 60-70% of intestinal bacteria in control-treated animals.
After one day, these bacteria represented a combined frequency of greater than 95% in
samples from antibiotic-treated but not control-treated animals, and subsequently
stabilized at a frequency of approximately 90% in all sampled compartments.
Outgrowths of the Bacteroidies phylum were not observed in previous metagenomic
studies that examined recovery of intestinal microbiota after antibiotic exposure
(Antonopoulos et al. 2009), likely representing differences in antibiotic type and
administration and highlighting the utility of temporal analyses in metagenomic studies. It
is intriguing to speculate that rapid increases in Bacteroidies frequency after antibiotic
initiation may be responsible for associations between early antibiotic exposure in
humans and increased susceptibility to allergic inflammation.
Significant reductions in the frequency of bacteria belonging to the Firmicute
phylum were also detected in samples from antibiotic-treated as compared to controltreated animals. This bacterial phylum has been shown to be present in an increased
frequency in obese patients as compared to healthy individuals (Ley et al. 2006) and
may provide the host an enhanced ability to extract energy from otherwise indigestible
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dietary polysaccharides (Turnbaugh et al. 2006). As such, antibiotic treatment may result
in a reduced capacity for energy harvest by the host which has implications for
prolonged antibiotic treatment in patients. In addition, these findings highlight a possible
role for antibiotics as a means of modulating intestinal bacterial communities in future
treatments for obesity (Ley et al. 2006).
Consistent with previous studies, increased frequencies of Enterobacteriaceae,
as well as other members of the Proteobacteria phyla were detected in samples from
antibiotic-treated as compared to control-treated animals (Antonopoulos et al. 2009).
The Enterobacteriaceae include a number of nosocomial pathogens, with considerable
antibiotic resistance, including Escherichia, Enterobacter, and Salmonella. Given that
DNA transfer between intestinal bacteria plays a role in shaping bacterial communities
(Ley, Peterson & Gordon 2006, Grasselli et al. 2008) and in the development of
pathogenic, antibiotic-resistant organisms (Karami et al. 2007), Enterobacteriaceae that
survive in an antibiotic exposed intestine may act as a clinically relevant reservoir that
could seed subsequent infections with antibiotic resistant bacteria. Outgrowth of C.
difficile, a common cause of antibiotic-associated colitis that is thought to colonize the
intestine when indigenous microbiota are disrupted by antibiotic use (De La Cochetiere
et al. 2008), was not observed as a result of our antibiotic treatment protocol. However,
this result is not unexpected as metronidazole and vancomycin, two antibiotics
commonly used to treat C. difficile colitis in humans, were included in the antibiotic
cocktails used in this study.
Analyses were extended to spatial examinations of antibiotic effects along the
length of the intestine, and between luminal and mucosal-associated bacterial
communities. It was found that luminal and stool pellet bacterial communities from naïve
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animals were similar, suggesting that examination of stool pellets is an adequate, rough
approximation of luminal communities (Eckburg et al. 2005). However, naïve animals
displayed significantly higher frequencies of Lactobacillus species in mucosal-associated
as compared to luminal communities, suggesting that distinct bacterial communities at
different anatomical locations may be relevant for mammalian physiology.
Upon antibiotic treatment, there were significant changes to both luminal and
mucosal-associated bacterial communities including increases in the Bacteroidies and
Proteobacter phyla, and reductions in the Firmicute phylum. In particular, significant
reductions in the frequency of mucosal-associated Lactobacillus species were observed
in antibiotic-treated as compared to control-treated animals. Lactobacillus species have
been used as ―probiotic‖ bacteria with mixed effectiveness in treating human diseases
(Betsi, Papadavid & Falagas 2008, Kozuch, Hanauer 2008). It may therefore be useful to
examine whether reductions in this potentially beneficial mucosal-associated bacterial
group are responsible for changes in immune homeostasis observed following antibiotic
treatment.
In summary, this chapter describes the development and characterization of a
new antibiotic treatment protocol that modifies intestinal microbiota without animal
dehydration. Deep sequencing analysis showed that antibiotic treatment causes
significant temporal and spatial alterations in bacterial groups that have been implicated
to have causative or therapeutic roles in human diseases. It is hoped that these findings
will provide a resource and framework for analysis and manipulation of intestinal
microbial communities in murine models of human infection and disease.
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Chapter 3: Commensal Bacterial-Derived Signals
Limit Allergic Inflammation in Mice
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3.1 Abstract
The prevalence and severity of allergic diseases have been increasing in the U.S. and
U.K. for more than fifty years. Recently, experimental and epidemiologic studies have
implicated commensal bacteria that colonize mammalian mucosal surfaces in influencing
T helper type 2 (TH2) cytokine-mediated inflammation and allergic disease. However, the
mechanisms by which the innate immune system recognizes commensal bacterialderived signals and influences the development of TH2 cell responses are poorly
understood. The data presented in this chapter indicate that commensal bacterialderived signals limit serum immunoglobulin E (IgE) levels and steady-state circulating
basophil populations, innate granulocytes implicated in the initiation and propagation of
TH2 cell responses. Consistent with dysregulated steady-state basophil responses
contributing to exaggerated allergic responses, antibiotic (ABX) treatment of mice
resulted in exaggerated basophil-mediated skin and airway inflammation, and the
development of enhanced basophil-dependent TH2 cell responses. Together, these
results indicate that commensal-derived signals act to limit steady-state circulating
basophil responses and the development of basophil-mediated allergic inflammation.

3.2 Introduction
Allergic diseases have reached pandemic levels (Eder, Ege & von Mutius 2006) and
represent a significant source of morbidity, mortality and healthcare cost (Bahadori et al.
2009). These chronic inflammatory diseases are characterized by interleukin (IL)-4, IL-5,
IL-9 and IL-13 production by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE)
production by B cells, and the recruitment of effector cells to sites of tissue inflammation

83

(Mowen, Glimcher 2004, Holgate 2008). It is thought that susceptibility to TH2 cytokinedependent allergic inflammation is determined by polymorphisms in mammalian genes
(Vercelli 2008) and environmental factors including diet and exposure to pollutants or
infectious agents (Gilliland 2009, Zeiger 2003, Ege et al. 2011). However, the specific
genetic and environmental stimuli that enhance allergy susceptibility, and how these
factors contribute to the development of allergic disease, are an ongoing field of
research.
The human intestine is colonized by 100 trillion microorganisms belonging to
each of the three domains of life (Eckburg, Lepp & Relman 2003). Of these, bacteria are
the most abundant – the colon is home to trillions of commensal bacteria (Whitman,
Coleman & Wiebe 1998) with a diversity of at least 1,000 species (Ley, Peterson &
Gordon 2006). Epidemiologic studies have identified associations between alterations in
the composition of commensal bacterial communities and the development of allergic
disease. For example, infants who develop allergies display altered commensal
populations early in life (Kalliomaki et al. 2001), and children who have undergone
treatment with broad-spectrum antibiotics are at an increased risk of developing allergic
diseases (Marra et al. 2009, Kummeling et al. 2007). Studies in animal model systems
have corroborated these findings and shown that commensal bacterial-derived signals
limit the development of TH2 cytokine-mediated allergic inflammation (Bashir et al. 2004,
Noverr et al. 2005, Noverr et al. 2004, Herbst et al. 2011). However, the innate immune
cells that are influenced by commensal bacterial-derived signals and modulate the
development

of

allergic

T H2

cytokine-dependent

inflammation

remain

poorly

characterized (Lambrecht, Hammad 2010, Paul, Zhu 2010).
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Recently, granulocytes including mast cells, eosinophils and basophils have
been shown to express MHC class II (Charles et al. 2010, Skokos et al. 2003, Padigel et
al. 2007), be potent sources of IL-4 and, depending on the stimulus, contribute to the
development of optimal TH2 cytokine responses (Gessner, Mohrs & Mohrs 2005, Mohrs
et al. 2005, Min et al. 2004). Given the proposed role for commensal bacteria in
influencing allergy susceptibility, and the identification of granulocytes as innate cells
that promote TH2 cytokine-mediated inflammation, we sought to test whether
commensal-derived signals influence granulocyte homeostasis or allergen-induced TH2
cell responses.
In this chapter, oral delivery of broad-spectrum antibiotics was employed to
interrogate the influence of commensal bacterial-derived signals on circulating basophil
populations. Both deletion of bacterial communities through the use of germ-free mice,
and depletion of bacterial communities using antibiotic treatment, were associated with
elevated serum IgE levels, increased circulating basophil populations and exaggerated
basophil-mediated TH2 cytokine-dependent allergic inflammation. These findings identify
basophils as an important innate immune cell population that is expanded in the
circulation of antibiotic-treated or germ-free mice and may contribute to exaggerated TH2
cytokine-mediated allergic inflammation in these models.

3.3 Methods
3.3.1 Animals
BALB/c or C57BL/6 mice were purchased from Jackson or Charles River Laboratories.
Germ-free mice were provided by the Penn Gnotobiotic Mouse Facility. BaS-TRECK
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mice were obtained from M. Kubo, IL-4/eGFP reporter mice were obtained from M.
Mohrs. All mice used were 8–24 weeks of age. Conventional animals were bred and
housed in specific pathogen-free conditions at the University of Pennsylvania. All
experiments were performed under Institutional Animal Care and Use Committee
(IACUC) approved protocols and in accordance with the guidelines of the IACUC of the
University of Pennsylvania.

3.3.2 Reagents and Treatments
For antibiotic treatment, mice were fed autoclaved water or autoclaved water
supplemented with ampicillin (0.5 mg/mL), gentamicin (0.5 mg/mL), metronidazole (0.5
mg/mL), neomycin (0.5 mg/mL), and vancomycin (0.25 mg/mL) continuously via water
bottle for four weeks. In the occasional event of poor animal oral hydration, both control
and antibiotic water was supplemented with artificial sweetener. For MC903, mice were
treated daily for 7 days on the ear with 10 µL of ethanol or ethanol containing 2 nMol of
MC903 (Tocris Bio. Sci.) as described previously (Li et al. 2006). For house dust mite
(HDM) allergen-induced airway inflammatoin, mice were treated on day 0, 7, 14
intranasally with 50 µL of PBS or PBS containing 100µg of D. pteronyssinus extract
(Greer) and sacrificed on day 17 as described previously (Hammad et al. 2010). For
papain, mice were injected subcutaneously in contralateral footpads with 50 ul of PBS or
PBS containing 50 µg of papain (Calbiochem) as described previously (Sokol et al.
2008) and were sacrificed on D3 or D4 post injection for basophil or TH2 cell analysis.
For basophil depletion by anti-FcεRIα treatment, mice were treated by intraperitoneal
injection (i.p.) with 10 µg of MAR1 or isotype antibody (eBioscience) on D-3, -2, -1. For
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basophil depletion by diphtheria toxin (DT) treatment, littermate control or BaS-TRECK
mice were treated with 750 ng DT i.p. on day -2 and D0 prior to papain exposure.

3.3.3 Flow Cytometry
Blood, spleen, lung, bronchoalveolar lavage, ears or lymph nodes were collected at
necropsy, lungs and ears were digested with collagenase and dispase, homogenized by
passing through a 70 μm nylon mesh filter, purified of red blood cells by histopaque
(Sigma-Aldrich) or RBC lysis, and stained with anti-mouse fluorochrome-conjugated
monoclonal antibodies against B220, CD3ε, CD4, CD8, CD11c, CD19, CD40, CD45.1,
CD49b, CD69, CD80, CD86, CD117, FcεRIα, FcγR, Gr-1, IgE, IL-4, MHC-I or MHC-II
(BD Bioscience, BioLegend, eBioscience). Cells were acquired on a FACSCanto II or
LSR II with DiVa software (BD Bioscience) and analyzed with FlowJo software (version
8.7.1; Tree Star).

3.3.4 Culture, ELISA and Histology
Tissues were harvested and single cell suspensions were made. LNs were cultured for
2-4 days at 200-250,000 cells in 200ul of complete media in the presence or absence of
αCD3 and αCD28 (0.5-1.0 µg/mL). For intracellular cytokine analysis, cells were
stimulated for 4 hours in the presence of 50 ng/mL phorbol 12-myristate 13-acetate
(Sigma-Aldrich) and 750 ng/mL ionomycin (Sigma-Aldrich) in the presence of 10 µg/mL
Brefeldin A (Sigma-Aldrich), treated with Fix/Perm (eBioscience), and stained
intracellularly. IgE and IL-4 from serum or cell-free culture supernatants were assayed
by sandwich ELISA (BD Bioscience). At necropsy, skin or lung tissue sections were
removed and fixed in 4% paraformaldehyde and embedded in paraffin. 5 µM sections
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were cut and stained with hematoxylin and eosin. Orthokeratosis was quantified with NIS
Elements BR imaging software (Nikon).

3.3.5 Statistics
Results shown as mean ± standard deviation for individual animals. Statistical
significance was determined by two-tailed Mann-Whitney test or unweighted means
analysis two-way ANOVA as indicated. Results were considered significant at P ≤ 0.05
(*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001).

3.4 Results
3.4.1 Commensal bacteria limit serum IgE levels and circulating basophils
As reported previously, oral antibiotic treatment (ABX) resulted in significant increases in
serum IgE levels (Sudo et al. 1997, McCoy et al. 2006) (Figure 11a). As IgE influences
granulocyte homeostasis (Kalesnikoff et al. 2001, Kitaura et al. 2003), we investigated
whether ABX-induced elevations in IgE were associated with alterations in the frequency
or number of circulating eosinophils, mast cells or basophils. ABX-treatment did not alter
blood eosinophil (Figure 11b,c) or mast cell populations (Figure 11d,e). However,
frequencies and numbers of basophils (identified as non-B, non-T (NBNT), CD117-,
CD49b+, FcεRIα+) were significantly increased in the blood (Figure 11f,g) and spleen
(Figure 11h,i) of ABX-treated compared to conventionally (CNV)-reared mice. Further,
basophils from ABX-treated mice displayed increased levels of surface-bound IgE
compared to controls (Figure 12a), while expression of other surface markers (CD69,
CD123, CD200R, FcεRIα, FcγR, Gr1) were unaltered (Figure 12b).
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Figure 11: Elevated steady-state serum IgE levels and circulating basophils in antibiotic-treated
mice
(a) Serum IgE from conventionally-reared (CNV) or antibiotic-treated (ABX) mice as measured by ELISA. (b) Flow
cytometric analysis of blood eosinophils from CNV or ABX mice. Numbers adjacent to outlined areas indicate percent
cells in each gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (c) Number of eosinophils per mL of blood from CNV
or ABX mice. (d) Flow cytometric analysis of peritoneal cavity (PECS) mast cells from CNV or ABX mice. Gated on CD3 ,
CD4 , CD8 , CD19 cells. (d) Number of mast cells isolated from the PECS of CNV or ABX mice. (e) Flow cytometric
analysis of blood basophils from CNV or ABX mice. Numbers adjacent to outlined areas indicate percent cells in each
gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (f) Number of basophils per mL of blood from CNV or ABX mice.
(g) Flow cytometric analysis of spleen basophils from CNV or ABX mice. (h) Number of spleen basophils from CNV or
ABX mice. Data representative of three or more independent experiments (mean ± S.D.; CNV, n=5-18; ABX, n=5; *, P ≤
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Figure 12: Increased surface-bound IgE on basophils from antibiotic-treated mice
(a) Mean fluorescence intensity of surface IgE on blood basophils from conventionally-reared (CNV) or antibiotic+
+
treated (ABX) mice as determined by flow cytometry. Gated on CD3 , CD4 , CD8 , CD19 , CD117 , CD49b , FcεRIα cells.
(b) Mean fluorescence intensity of surface CD69, CD123, CD200R, FcεRIα, FcγR and Gr1 on blood basophils from CNV
or ABX mice as determined by flow cytometry. Data representative of three or more independent experiments
(Negative = negative cell population).

ABX treatment does not eliminate all commensal bacteria (Hill et al. 2009). To
investigate whether steady-state levels of IgE or basophil populations were altered in the
absence of live microbial stimuli, germ-free (GF) mice were employed (Smith, McCoy &
Macpherson 2007). Consistent with the effects of ABX treatment, GF mice exhibited
increased serum IgE levels (Figure 13a), increased frequencies and numbers of
basophils in the blood (Figure 13b,c) and spleen (Figure 13d,e), and increased
basophil-surface-bound IgE levels (Figure 13f) compared to CNV-reared mice.
Consistent with commensal-derived signals being sufficient to limit serum IgE levels and
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circulating basophil populations, conventionalization of GF mice resulted in reductions in
serum IgE levels (Figure 13g), and blood and spleen basophil populations (Figure
13h,i). Collectively, these data indicate that commensal bacterial-derived signals limit
serum IgE levels and circulating basophil populations in the steady-state.
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Figure 13: Elevated steady-state serum IgE levels and circulating basophils in germ-free mice
(a) Serum IgE from conventionally-reared (CNV) or germ-free (GF) mice as measured by ELISA. (b) Flow cytometric
analysis of blood basophils from CNV or GF mice. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (c) Number of
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GF-CNV mice. (i) Frequency of spleen basophils from CNV, GF or GF-CNV mice. Data representative of three or more
independent experiments (mean ± S.D.; CNV, n=5-18; GF, n=3-10; CNV-GF, n=3; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤
0.001). Experiments performed in collaboration with Dmytro Kobuley.
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3.4.2 Commensal bacteria limit basophil-mediated allergic skin inflammation
Given the enhanced frequencies and numbers of circulating steady-state basophils in
ABX-treated mice, we next examined whether commensal-derived signals influence
basophil effector function in vivo. Basophils contribute to the development of atopic
dermatitis-like lesions in mice exposed to the vitamin D3 analogue MC903 (Li et al.
2006, Siracusa et al. In Press). To test whether commensal-derived signals influence
MC903-elicited inflammation, CNV-reared or ABX-treated mice were exposed to MC903,
and IgE levels, basophil responses and skin inflammation were examined. Compared to
controls, MC903 exposure in ABX-treated mice resulted in significantly elevated serum
IgE levels and blood basophil populations (Figure 14a,b), increased recruitment of
basophils to inflamed skin (Figure 14c), and increased skin basophil surface-bound IgE
levels (Figure 14d). Concurrently, compared to CNV-reared controls, ABX-treated mice
displayed evidence of enhanced atopic dermatitis-like changes (Figure 14e)
characterized by significantly more orthokeratosis compared to CNV-reared mice
(Figure 14f), a pathological finding associated with atopic dermatitis in patients (Lobitz,
Dobson 1956). Together, these results indicate that commensal bacterial-derived signals
limit the development of basophil-mediated inflammation of the skin.
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3.4.3 Commensal bacteria limit basophil-mediated allergic airway inflammation
Basophils also contribute to allergic airway responses to inhaled house dust mite
allergen (HDM) (Hammad et al. 2010). To test whether commensal-derived signals
influenced the development of HDM-induced airway inflammation, CNV-reared or ABXtreated mice were exposed to HDM and TH2 cell responses, systemic and local innate
cell responses, and airway inflammation were examined. Compared to CNV-reared
mice, ABX-treated mice displayed increased HDM-elicited TH2 cell responses in the
draining mediastinal lymph node (LN) as determined by the IL-4/eGFP reporter system
(Mohrs et al. 2005) (Figure 15a), increased mediastinal LN TH2 cell-derived IL-4
responses (Figure 15b), and increased blood basophil responses (Figure 15c).
Concurrently, compared to CNV-reared controls, ABX-treated mice displayed increased
HDM-elicited bronchoalveolar lavage (BAL) and lung eosinophil responses (Figure 15d)
and exaggerated airway inflammation (Figure 15e) characterized by exaggerated
cellular infiltrates and airway destruction. Together, these findings indicate that
commensal-derived signals limit basophil-mediated allergic inflammation in the lung.
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Figure 15: Exaggerated HDM-induced airway inflammation in antibiotic-treated mice
+

+

(a) Flow cytometric analysis of day 18 mediastinal lymph node (MLN) IL-4/eGFP CD4 TH2 cells from conventionallyreared (CNV) or antibiotic-treated (ABX) mice treated with PBS or house dust mite (HDM) antigen. Gated on CD8 ,
+
CD19 , CD4 cells. (b) IL4 in in supernatants of MLN cell cultures from CNV or ABX mice treated with HDM as
measured by ELISA. (c) Flow cytometric analysis of blood basophils from control CNV or ABX mice treated with PBS or
HDM. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (d) Frequency of eosinophils in bronchoalveolar lavage or lung
samples from HDM-treated CNV or ABX mice. (e) Histological sections of lungs from CNV or ABX mice treated with
PBS or HDM and stained with H&E (Large Bar = 100 µM; Small Bar = 20 µM). Arrows indicate eosinophil infiltrates.
Data representative of two or more independent experiments (mean ± S.D.; CNV, n=2-5; ABX, n=2-5).

3.4.4 Commensal bacteria limit basophil-mediated TH2 cell responses
In addition to their roles as effector cells, basophils are recruited to draining LNs early in
the response to infectious (Perrigoue et al. 2009) or allergic (Yoshimoto et al. 2009,
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Sokol et al. 2008) stimuli where they cooperate with DCs to promote optimal T H2 cell
responses (Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). To test
whether ABX-treated mice exhibited altered allergen-induced TH2 cell responses, CNVreared or ABX-treated IL-4/eGFP reporter mice were exposed to papain, a cysteine
protease associated with occupational allergy in humans (Novey et al. 1979) and TH2
cell responses in mice (Sokol et al. 2008). Following PBS-treatment, similar frequencies
of basophils (Figure 16a) and IL-4/eGFP+CD4+ TH2 cells (Figure 16b) were observed in
the LNs of CNV-reared or ABX-treated mice. However, following exposure to papain,
ABX-treated mice exhibited increased frequencies of LN basophils (Figure 16c) and IL4/eGFP+CD4+ TH2 cells (Figure 16d) compared to controls. Depletion of basophils by
administration of anti-FcεRIα antibody (Sokol et al. 2008) resulted in a reduction in the
frequency of LN basophils (Fig. 16e), and reduced frequencies (Fig. 16f) and numbers
(Fig. 16g) of papain-elicited IL-4/eGFP+CD4+ TH2 cells, indicating that basophils
contribute to the exaggerated TH2 cell responses observed in ABX-treated mice.
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Figure 16: Exaggerated Papain-induced TH2 cell responses in antibiotic-treated mice
(a) Flow cytometric analysis of day 3 popliteal LN (pLN) basophils from conventionally-reared (CNV) or antibiotictreated (ABX) mice treated with PBS and Isotype control antibody. Numbers adjacent to outlined areas indicate
percent cells in each gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (b) Flow cytometric analysis of day 4 pLN IL+
+
4/eGFP CD4 TH2 cells from CNV or ABX mice treated with PBS and Isotype control antibody. Gated on CD8 , CD19
cells. (c) Flow cytometric analysis of day 3 pLN basophils from CNV or ABX mice treated with Papain and Isotype
+
+
control antibody. (d) Flow cytometric analysis of day 4 pLN IL-4/eGFP CD4 TH2 cells from CNV or ABX mice treated
with Papain and Isotype control antibody. (e) Flow cytometric analysis of day 3 pLN basophils from CNV or ABX mice
+
+
treated with Papain and anti-FcεRIα (αFcεRIα) antibody. (f) Flow cytometric analysis of day 4 pLN IL-4/eGFP CD4 TH2
+
+
cells from CNV or ABX mice treated with Papain and αFcεRIα antibody. (g) Number of day 4 pLN IL-4/eGFP CD4 TH2
cells from CNV or ABX mice treated with PBS or Papain and Isotype control (-) or αFcεRIα (+) antibody (means of three
experiments ± S.D.; CNV-PBS-ISO, n=4-5; CNV-PAP-ISO, n=4-5; ABX-PBS-ISO, n=5; ABX-PAP-ISO, n=5-8; CNV-PAPαFcεRIα, n=2; ABX-PAP-αFcεRIα, n=2-6; significance determined by 2 way ANOVA). Data representative of three or
more independent experiments ((mean ± S.D.; CNV, n=2-5; ABX, n=2-5; ǂ, P ≤ 0.06; *, P ≤ 0.05). Experiments
performed in collaboration with Mark Siracusa.

3.4.5 Basophils contribute to exaggerated TH2 cell responses in antibiotic-treated
mice
Inflammatory dendritic-cells (DCs) are important for the development of optimal TH2 cell
responses to some allergens (Hammad et al. 2010). To investigate the influence of
commensal-derived signals on DC populations, DCs were examined in CNV-reared or
ABX-treated mice. Steady-state DC frequencies were similar between CNV-reared or
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ABX-treated mice (data not shown), as was DC expression of MHC-I, MHC-II, CD40,
CD80, CD86, or FcεRIα (Figure 17a,b), indicating that commensal-derived signals do
not significantly influence circulating DC populations in the steady-state.
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Figure 17: Antibiotic treatment does not influence dendritic cell surface phenotype in mice
(a) Mean fluorescence intensity of surface MHC-I, MHC-II, CD40, CD80, CD86 and FcεRIα on splenic DCs from
conventionally-reared (CNV) or antibiotic-treated (ABX) mice as determined by flow cytometry. Gated on CD3 , CD4 ,
+
+
CD8 , CD19 , MHC-II , CD11c cells. (b) Mean fluorescence intensity of MHC-I, MHC-II, CD40, CD80, CD86 and FcεRIα
on splenic DCs from CNV or ABX mice. Data representative of three or more independent experiments (mean ± S.D.;
CNV, n=5; ABX, n=5). Experiments performed in collaboration with Michael Abt.

As inflammatory DCs express FcεRIα (Hammad et al. 2010), we next examined
whether commensal-derived signals influence allergen-induced non-basophil FcεRIα+
cell populations in the LN. Papain-elicited LN non-basophil FcεRIα+ cell populations were
similar between CNV-reared or ABX-treated mice (Figure 18a) and ABX-treatment did
not significantly influence non-basophil FcεRIα+ cell populations expressing MHC-II or
CD40 (Figure 18b,c), indicating that non-basophil FcεRIα+ cell responses are not
significantly influenced by commensal-derived signals in this setting. As inflammatory
DCs express FcεRIα, and have been shown to be influenced by anti-FcεRIα antibody
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treatment (Hammad et al. 2010), we examined the effect of anti-FcεRIα antibody
treatment on LN non-basophil FcεRIα+ cell populations. Compared to Isotype treated
controls, we did not observe a significant difference in papain-elicited non-basophil
FcεRIα+ cell populations in the LNs of CNV-reared or ABX-treated mice upon antiFcεRIα antibody treatment (Figure 18a), nor did we find a significant effect of antiFcεRIα antibody treatment on non-basophil FcεRIα+ cell populations expressing MHC-II
or CD40 (Figure 18c,b). Together, these findings indicate that neither steady-state DC
responses, nor papain-elicited non-basophil FcεRIα+ LN cell responses, are significantly
dysregulated in ABX-treated compared to CNV-reared mice.
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Figure 18: Anti-FcεRIα treatment does not influence non-basophil FcεRIα+ lymph node antigen
presenting cells in antibiotic-treated mice
-

+

(a) Flow cytometric analysis of pLN CD49b FcεRIα cells from conventionally-reared (CNV) or antibiotic-treated (ABX)
mice treated with Papain and isotype or αFcεRIα antibody. Numbers adjacent to outlined areas indicate percent cells
+
+
in each gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (b) Frequencies of pLN CD49b , FcεRIα , MHC-II cells
+
from CNV or ABX mice treated with Papain and isotype or αFcεRIα antibody. (c) Frequencies of pLN CD49b , FcεRIα ,
+
CD40 cells from CNV or ABX mice treated with Papain and isotype or αFcεRIα antibody. Data representative of two or
more independent experiments (mean ± S.D.; CNV, n=2-3; ABX, n=2-3).
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Due to concerns that αFcεRIα treatment might be influencing FcεRIα+
inflammatory DC populations, we adopted a loss-of-function approach complementary to
anti-FcεRIα antibody treatment by utilizing a diphtheria toxin (DT)-dependent basophil
depletion mouse system (BaS-TRECK) (Siracusa et al. In Press). ABX-treatment
resulted in increased frequencies of circulating basophils (Figure 19a) and frequencies
(Figure 19b) and numbers (Figure 19c) of papain-elicited TH2 cells in the LN compared
to CNV-reared mice. Importantly, DT-treatment resulted in efficient depletion of
basophils (Figure 19a) and reductions in the frequency (Figure 19b) and number
(Figure 19c) of papain-elicited TH2 cells in BaS-TRECK but not control mice. Together,
these data indicate that basophils contribute to the exaggerated allergen-induced TH2
cell responses observed in ABX-treated mice.
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Figure 19: Basophils contribute to exaggerated TH2 cell responses in antibiotic-treated mice
(a) Flow cytometric analysis of blood basophils from conventionally-reared (CNV) or antibiotic-treated (ABX), control
or BaS-TRECK mice treated with diphtheria toxin (DT). Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (b) Flow
cytometric analysis of pLN CD4+ TH2 cells from CNV or ABX, control or BaS-TRECK mice treated with papain and DT.
+
+
+
Gated on CD8 , CD19 , CD4 cells. (c) Number of day 4 pLN CD4 , IL-4 TH2 cells from CNV (-) or ABX (+), control (-) or
BaS-TRECK (+) mice treated with PBS (-) or Papain (+) and DT. Data representative of two independent experiments
(Control, n=2-3; BaS-TRECK, n=1-3; TH2 cells determined by expression of IL-4 or IL-5). Experiments performed in
collaboration with Mario Noti.
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3.5 Discussion
Although the prevalence and severity of allergic diseases have been increasing in the
U.S. and U.K. for the past fifty years (Eder, Ege & von Mutius 2006), the genetic (Vercelli
2008) and environmental (Gilliland 2009, Zeiger 2003, Ege et al. 2011) factors that
influence allergy susceptibility are not well understood. Recently, epidemiologic (Marra
et al. 2009, Kummeling et al. 2007, Kalliomaki et al. 2001) and experimental (Bashir et
al. 2004, Noverr et al. 2005, Noverr et al. 2004, Herbst et al. 2011) studies have
identified associations between alterations in the composition of commensal bacterial
communities and the development of allergic TH2 cytokine-dependent inflammation.
However, the influence of commensal bacterial-derived signals on innate immune cells
known to influence the development of TH2 cytokine-dependent inflammation remain
poorly characterized (Hill, Artis 2010, Lambrecht, Hammad 2010, Paul, Zhu 2010).
Data in this chapter identify a role for commensal bacterial-derived signals in
limiting steady-state serum IgE levels and circulating basophil populations. These
findings are of particular interest given that basophils have recently been shown to
express MHC class II (Charles et al. 2010, Skokos et al. 2003, Padigel et al. 2007), be
potent sources of IL-4 and, depending on the stimulus, contribute to the development of
optimal TH2 cytokine-dependent allergic inflammation (Gessner, Mohrs & Mohrs 2005,
Mohrs et al. 2005, Min et al. 2004). An alternative explination for the elevations in
basophils observed in ABX-treated mice is the depletion of another cell population.
Germ-free and antibiotic treated mice are considered to be lymphpenic, supporting this
hypothesis (Hudson, Luckey 1964, Hooijkaas et al. 1984). However, there are lines of
evidence that suggest that the elevations in circulating basophils we observe are not a
consequence of depletion of another cell population. First, basophil numbers as well as
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frequencies were significantly elevated in ABX-treated compared to CNV-reared mice.
Second, a stringent gating strategy was utlilized to ensure that T and B cells were
excluded from our basophil plots, minimizing the likelihood that lymphpenia would
influence our results. Third, increases were selective to basophils as eosinophil and
mast cell populations were not apparently influenced by ABX-treatment. Finally, ABXtreated mice displayed elevated basophil responses in three models of allergic
inflammation. Together, these results suggest that commensal bacterial-derived signals
act to actively limit circulating basophil populations in the steady-state.
Basophils from ABX-treated mice did not display alterations in surface
phenotype, suggesting that commensal-derived signals influence quantitative rather than
qualitative aspects of basophil biology. However, this does not exclude the possibility
that functional heterogeneity exists between basophils from CNV-reared or ABX-treated
mice. Additionally, antibiotic-treated mice displayed exaggerated basophil-mediated skin
inflammation in an innate model of atopic-dermatitis and allergic airway inflammation in a
model of asthma. While these findings are consistant with primarirly quantative
alterations to basophil biology in ABX-treated mice, functional heterogeneity between
basophils from CNV-reared or ABX-treated mice could also be contributing to these
phenotypes. Together, these findings suggest that in addition to limiting circulating
basophil populations in the steady-state, commensal bacterial-derived signals act to limit
basophil-mediated allergic responses.
In addition to their roles as effector cells, basophils are recruited to draining LNs
early in the response to infectious (Perrigoue et al. 2009) or allergic (Yoshimoto et al.
2009, Sokol et al. 2008) stimuli where they cooperate with DCs to promote optimal TH2
cell responses (Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). Data in

102

this chapter indicate that ABX-treated mice display elevated basophil LN recruitment and
exaggerated LN TH2 cell responses to allergens compared to CNV-reared mice. Nonbasophils APC populations did not seem to be significantly influenced by commensal
bacterial-derived signals in our experimental systems. Importantly, basophils were
shown to contribute to the development of exaggerated allergen-induced TH2 cell
responses using two methods of basophil depletion. In both systems, depletion of
basophils in ABX-treated mice reduced TH2 cell numbers to levels similar to those seen
in CNV-reared mice, however, TH2 cell frequencies were consistently slightly higher
upon basophil depletion in ABX-treated compared to CNV-reared mice. These findings
suggest that cell types other than basophils may be contributing to the exaggerated TH2
cell frequencies observed in ABX-treated mice. Together, these findings indicate that
commensal bacterial-derived signals limit disease in models of basophil effector
function, and basophil-mediated TH2 cell responses. Together, they identify basophils as
a potential therapeutic target to prevent the development or propagation of allergic
diseases in patients.
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Chapter 4: Regulation of circulating basophil
populations by immunoglobulin E
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4.1 Abstract
Data presented in Chapter 3 identified a role for commensal bacterial-derived signals in
limiting serum immunoglobulin E (IgE) levels, steady-state circulating basophil
populations, and basophil-mediated TH2 cytokine-dependent allergic inflammation.
However, the mechanisms through which commensal-derived signals limit circulating
basophil populations is not understood. This chapter describes a previously
unrecognized axis of basophil homeostasis that is mediated by IgE. Serum IgE levels
correlated with circulating basophil populations in CNV-reared and ABX-treated mice, as
well as human patients with hyperimmunoglobulinemia E syndrome. Steady-state serum
IgE levels and circulating basophil populations were dysregulated by B cell-intrinsic
deletion of MyD88, providing insights into one cell-intrinsic mechanism by which
commensal-derived signals may influence circulating basophil populations.

4.2 Introduction
Data in Chapter 3 identified a previously unappreciated role for commensal bacterialderived signals in limiting serum IgE levels, circulating steady-state basophil populations,
and basophil-mediated allergic inflammation. IgE sensitizes mast cells and basophils by
binding to the high affinity IgE receptor (FcεRIα) and, upon re-exposure to the IgEspecific antigen, causes the release of cytokines, chemokines, and other chemical
mediators that result in the pathological and clinical sequelae of immediate
hypersensitivity reactions (Galli et al. 2005, Kalesnikoff, Galli 2008). Additionally, recent
findings suggest that IgE may influence granulocyte homeostasis in the absence of an
antigen. For example, IgE has been shown to upregulate the expression of FcεRIα on
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mast cells and basophils (Lantz et al. 1997, Yamaguchi et al. 1997), and FcεRIα
expression on basophils positively correlates with serum IgE levels in human blood
(Saini et al. 2000). Antigen-independent immunoregulatory roles for IgE are supported
by studies in humans and animal models that indicate that IgE is spontaneously
produced at low levels in the absence of allergic or infectious stimuli (Gould, Sutton
2008). Induced by a mechanism independent of MHC class II cognate help, the function
of so termed ―natural‖ IgE is not well understood, although it has been hypothesized to
provide a link between the innate immune system and the initiation and/or propagation of
allergic responses (McCoy et al. 2006).
Data presented in this chapter identify a previously unappreciated role for IgE in
influencing basophil homeostasis. Serum IgE levels were found to correlate with
circulating basophil populations in CNV-reared and ABX-treated mice, as well as human
patients with hyperimmunoglobulinemia E syndrome. Steady-state serum IgE levels and
circulating basophil populations were elevated following B cell-intrinsic deletion of
MyD88, providing insights into one cell-intrinsic mechanism by which commensalderived signals may influence serum IgE levels and circulating basophil populations.
Together, these results provide therapeutically relevant insights into the cellular and
molecular mechanisms by which commensal bacterial-derived signals influence
susceptibility to allergic disease.
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4.3 Methods
4.3.1 Animals
BALB/c, C57BL/6 or Rag1-/- mice were purchased from Jackson or Charles River
Laboratories. Germ-free mice were provided by the Penn Gnotobiotic Mouse Facility. Il4/- mice were obtained from P. Scott, Igε-/- mice were obtained from H. Oettgen, NOD1-/mice were obtained from J. Weiser, Myd88-/- mice were provided by D. LaRosa. All mice
used were 8–24 weeks of age. Conventional animals were bred and housed in specific
pathogen-free conditions at the University of Pennsylvania. All experiments were
performed under Institutional Animal Care and Use Committee (IACUC) approved
protocols and in accordance with the guidelines of the IACUC of the University of
Pennsylvania.

4.3.2 Reagents and Treatments
For antibiotic treatment, mice were fed autoclaved water or autoclaved water
supplemented with ampicillin (0.5 mg/mL), gentamicin (0.5 mg/mL), metronidazole (0.5
mg/mL), neomycin (0.5 mg/mL), and vancomycin (0.25 mg/mL) continuously via water
bottle for four weeks. In the occasional event of poor animal oral hydration, both control
and antibiotic water was supplemented with artificial sweetener. For IgE transfer, Rag1-/or Igε-/- mice were treated i.p. with 50 µg of control IgG or IgE (BD Bioscience) daily for
seven days. For IgE depletion, mice were treated i.p. with 200 µg of control IgG or
Omalizumab (Genentech) daily for seven days. For CpG treatment, mice were treated
i.p. once weekly during the course of ABX treatment with 100 µl of PBS containing 100
µg of control GpC-Phos (5’-ZOOFZEFEOZZOOZEFEZOZT-3’) or CpG-Phos (5’ZOOFZEFOEZZOOZEFOEZZT-3’).
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4.3.3 Flow Cytometry and ELISA
Blood, spleen or bone marrow were collected at necropsy, homogenized by passing
through a 70 μm nylon mesh filter, purified of red blood cells by histopaque (SigmaAldrich) or RBC lysis, and stained with anti-mouse fluorochrome-conjugated monoclonal
antibodies against B220, CD3ε, CD4, CD8, CD19, CD49b, CD117, CD123, CD200R,
FcεRIα, IgE, IgM (BD Bioscience, BioLegend, eBioscience). Human blood samples were
obtained from DOCK8- or control patients with participant consent, assent, and/or
parental consent as appropriate under protocols approved by the Children's Hospital of
Philadelphia and the Ludwig Maximilians University Institutional Review Boards. PBMCs
were isolated by Ficoll (GE) gradient and stained with anti-human fluorochromeconjugated monoclonal antibodies against CD11c, CD19, CD117, CD123, FcεRIα, IgE
or TCR (BD Bioscience, eBioscience) and fixed with 4% PFA. Cells were acquired on a
FACSCanto II or LSR II with DiVa software (BD Bioscience) and analyzed with FlowJo
software (version 8.7.1; Tree Star). Cells were sorted with a FACSAria (BD Bioscience).
Purified B or T cells were transferred by intraperitoneal injection into Rag1-/- recipients
and allowed to reconstitute for 6-8 weeks. Murine IgE was assayed by sandwich ELISA
(BD Bioscience). Human IgE levels were determined by sandwich ELISA or chart
review.

4.3.5 Statistics
Results shown as mean ± standard deviation for individual animals. Statistical
significance was determined by two-tailed Mann-Whitney test or unweighted means
analysis two-way ANOVA as indicated. Results were considered significant at P ≤ 0.05
(*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001).
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4.4 Results
4.4.1 Serum IgE levels correlate with circulating basophil populations in antibiotictreated mice
Previous reports demonstrated that IgE regulates mast cell homeostasis (Kalesnikoff et
al. 2001, Kitaura et al. 2003) and IgE has been hypothesized to have similar effects on
basophils (Xiang, Moller & Nilsson 2006). Based on the observation that serum IgE
levels were increased in ABX-treated mice (Figure 11a), the relationship between
elevated IgE levels and increased basophil populations observed in ABX-treated mice
was examined. Serum IgE levels significantly correlated with circulating basophil
numbers in CNV-reared or ABX-treated mice (Figure 20a), suggesting that IgE
produced by B cells may influence basophil homeostasis. To test whether the increase
in circulating basophils observed in ABX-treated mice was dependent on lymphocytes,
recombination activating gene 1-deficient mice (Rag1-/-) (Mombaerts et al. 1992) were
employed. Consistent with a role for IgE produced by B cells in regulating basophil
homeostasis, blood basophil frequencies and numbers were similar between CNVreared and ABX-treated Rag1-/- (Figure 20b,c) or GF Rag1-/- (Figure 20d,e) mice. As IL4 is necessary for IgE production by B cells (Kopf et al. 1993, Delphin, Stavnezer 1995),
IL-4-deficient mice (Il4-/-) were utilized to test the influence of IL-4 on IgE levels and
basophil responses in ABX-treated mice. ABX-treatment of wild-type (WT) mice resulted
in increased serum IgE levels (Figure 20f) and blood basophils (Figure 20g). In
contrast, IgE was not detected in Il4-/- mice (Figure 6f) and ABX-treatment of Il4-/- mice
had no effect on the frequency or number of blood basophils compared to CNV-reared
controls (Figure 20g,h) suggesting that IL-4-induced IgE production by B cells
contributes to the increased basophil responses observed in ABX-treated mice.
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Figure 20: Serum IgE levels correlate with circulating basophils in mice
(a) Statistical correlation of blood basophil number and serum IgE concentration (linear regression; r2 = 0.432, P =
0.038). (b) Flow cytometric analysis of blood basophils from conventionally-reared (CNV) or antibiotic-treated (ABX)
-/Rag1 mice. Numbers adjacent to outlined areas indicate percent cells in each gate. Gated on CD3 , CD4 , CD8 , CD19 ,
-/CD117 cells. (c) Number of basophils per mL of blood from CNV or ABX Rag1 mice. (d) Flow cytometric analysis of
-/blood basophils from CNV or germ-free (GF) Rag1 mice. (e) Number of basophils per mL of blood from CNV or GF
-/-/Rag1 mice. (e) Serum IgE from CNV or ABX, wild-type (WT) or Il4 mice as measured by ELISA (n.d., not detected).
-/(f) Flow cytometric analysis of blood basophils from CNV or ABX, WT or Il4 mice. (g) Number of basophils per mL of
-/blood from CNV or ABX Il4 mice. Data representative of three or more independent experiments (mean ± S.D.; CNV,
n=2-5; ABX, n=2-5; GF, n=6; **, P ≤ 0.01).
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4.4.2 Regulation of circulating basophil populations by commensal bacteria is
mediated by IgE
To directly test the role of IgE in mediating commensal bacterial-dependent regulation of
basophil responses, IgE-deficient (Igε-/-) mice were utilized. While ABX-treatment of WT
mice resulted in increased serum IgE levels (Figure 21a) and blood basophils (Figure
21b,c), IgE was not detected in Igε-/- mice (Figure 21a) and blood basophil populations
were not significantly different between CNV-reared or ABX-treated Igε-/- animals
(Figure 21b,c). Together, these results indicate that IgE is necessary to mediate the
exaggerated steady-state basophil responses observed in ABX-treated mice. To test
whether IgE was sufficient to promote the population expansion of circulating basophils,
Rag1-/- mice were treated with monoclonal IgE and blood basophil populations were
examined. Compared to controls, IgE transfer into Rag1-/- mice resulted in recovery of
serum IgE levels (Figure 21d) and significantly elevated frequencies and numbers of
blood basophils (Figure 21e,f). Collectively, these gain- and loss-of-function approaches
identify IgE as an important regulator of peripheral basophil responses in mice.
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Figure 21: IgE is necessary and sufficient to regulate circulating basophil populations in mice
-/-

(a) Serum IgE from conventionally-reared (CNV) or antibiotic-treated (ABX), wild-type (WT) or Igε mice as measured
-/by ELISA (n.d., not detected). (b) Flow cytometric analysis of blood basophils from CNV or ABX, WT or Igε mice. (c)
-/-/Number of basophils per mL of blood from CNV or ABX Igε mice. (d) Serum IgE from IgG (-) or IgE (+) treated Rag1
mice as measured by ELISA (n.d., not detected). (e) Flow cytometric analysis of blood basophils from IgG or IgE
-/-/treated Rag1 mice. (f) Number of basophils per mL of blood from IgG or IgE treated Rag1 mice. Data
representative of three or more independent experiments (mean ± S.D.; CNV, n=4-5; ABX, n=3-5; IgG, n=4; IgE, n=4; *,
P ≤ 0.05.).

4.4.3 Serum IgE levels and circulating basophil populations correlate in patients with
hyperimmunoglobulinemia E syndrome
Human patients with loss-of-function polymorphisms in the dedicator of cytokinesis 8
gene (DOCK8-) exhibit an autosomal recessive form of hyper-IgE syndrome (Engelhardt
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et al. 2009, Zhang et al. 2009) characterized by recurrent infections, increased
susceptibility to atopic eczema, and average serum IgE levels 10 times higher than
found in control patients (Grimbacher, Holland & Puck 2005). Based on the identification
of a role for IgE in regulating basophil responses in mice, we hypothesized that elevated
serum IgE levels resulting from genetic alteration in DOCK8- patients would be
associated with increased circulating basophil populations in these individuals. In
collaboration with Dr. Jordan Orange (CHOP) and Dr. Ellen Renner (Ludwig Maximilians
University), we examined serum IgE levels and circulating basophil populations in
DOCK8- patients. DOCK8- patients displayed elevated serum IgE levels compared to
controls (Grimbacher, Holland & Puck 2005) (Figure 22a). Human blood basophils
(identified

as

TCRβ-,

CD11c-,

CD19-,

CD117-,

CD123+,

FcεRIα+)

comprised

approximately 1% of NBNT compartment of controls (Figure 22b,d). In contrast, in four
of five DOCK8- patients examined basophils comprised approximately 3% of the NBNT
compartment (Figure 22c,d). Further, basophils isolated from DOCK8- patients
exhibited increased surface-bound IgE compared to controls (Figure 22e). These data
are consistent with IgE influencing basophil homeostasis in humans, and suggest that
elevated basophil responses in DOCK8- patients may contribute to the increased
susceptibility to atopic diseases observed in these patients.
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Figure 22: Serum IgE and basophils correlate in human patients and anti-IgE treatment
reduces serum IgE levels and circulating basophil populations in mice
(a) Serum IgE levels from control (Ctrl) patients or patients with polymorphisms in DOCK8 (DOCK8-) (mean ± S.D.; Ctrl,
n=15; DOCK8-, n=7). (b) Identification of blood basophils from control patients by flow cytometric analysis as TCRβ-,
CD11c-, CD19-, CD117-, FcεRIα+, CD123+ cells. Numbers adjacent to outlined areas indicate percent cells in each gate.
(c) Analysis of blood basophils from DOCK8- patients. (d) Frequency of basophils in blood from control or DOCK8patients (mean ± S.D.; Ctrl, n=8; DOCK8-, n=4). (e) Mean fluorescence intensity of surface-bound IgE on blood
basophils from control or DOCK8- patients. (f) Serum IgE from conventionally-reared (CNV) or germ-free (GF) mice
treated with control (-) or Omalizumab (Omab;+) antibody as measured by ELISA. (g) Flow cytometric analysis of
blood basophils from CNV or GF mice treated with control or Omalizumab antibody. Gated on CD3-, CD4-, CD8-,
CD19-, CD117- cells. (h) Number of basophils per mL of blood from CNV or GF mice treated with control or
Omalizumab antibody. Data representative of two or more independent experiments (mean ± S.D.; CNV, n=2-3; GF,
n=2-3; **, P ≤ 0.01; ***, P ≤ 0.001).
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Omalizumab is a monoclonal, humanized mouse anti-human IgE-specific
antibody and FDA approved anti-allergy drug (Pace et al. 2011, Holgate et al. 2009). To
test whether Omalizumab treatment influenced circulating basophil populations, CNVreared or GF mice were treated with Omalizumab or control antibody and serum IgE
levels and blood basophils were examined. As Omalizumab decreases FcεRIα
expression on basophils (Lin et al. 2004), basophils were identified as NBNT, CD117-,
CD49b+, CD200R+ cells (Shiratori et al. 2005). Omalizumab treatment of GF mice
resulted in reductions in serum IgE levels (Figure 22f), and reduced frequencies and
numbers of blood basophils (Figure 22g,h). Together, these results identify Omalizumab
as a potential therapeutic intervention to limit IgE-mediated increases in circulating
basophils.

4.4.4 MyD88-dependent commensal-derived signals limit serum IgE levels and
circulating basophil populations
It has been hypothesized that commensal bacterial-derived signals influence allergic
responses by signaling through pattern recognition receptors (PRRs) (Bashir et al. 2004,
Noverr et al. 2005). To interrogate the molecular mechanisms through which
commensal-derived signals influence serum IgE levels and circulating basophil
responses, mice deficient in myeloid differentiation primary response gene 88 (Myd88-/-),
a critical adaptor molecule that regulates signaling through multiple PRRs (Schnare et al.
2001), were utilized. As previously reported, CNV-reared Myd88-/- mice exhibited
significantly increased serum IgE levels compared to littermate controls (Schnare et al.
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2001) (Figure 23a). Associated with dysregulated IgE responses, compared to controls,
Myd88-/- mice displayed increased frequencies and numbers of peripheral basophils
(Figure 23b,c) and increased basophil-surface-bound IgE levels (Figure 23d) indicating
that MyD88 signaling pathways are important for limiting these responses. Nucleotidebinding oligomerization domain-containing protein 1 (NOD1) is a MyD88-independent
intracellular PRR that mediates innate and adaptive immunity by recognizing commensal
bacterial-derived signals (Clarke et al. 2010). To test whether NOD1 influenced steadystate circulating basophil populations, serum IgE levels and circulating basophils were
examined in control or NOD-1-deficient (Nod1-/-) mice. Neither serum IgE levels (Figure
23e) nor blood basophils were elevated in Nod1-/- compared to control mice (Figure
23f,g), indicating that NOD1 does not significantly influence steady-state serum IgE
levels or circulating basophil responses. To examine whether a MyD88-dependent
commensal bacterial-derived signal was sufficient to limit circulating basophils, ABXtreated mice were treated with CpG (Bashir et al. 2004, Hall et al. 2008), and serum IgE
levels and circulating basophil populations were examined. CpG treatment of ABXtreated mice resulted in reductions in serum IgE levels (Figure 23h) and blood basophil
frequencies and numbers (Figure 23i,j). Together, these findings implicate MyD88dependent commensal bacterial-derived signals in limiting serum IgE levels and
circulating basophil populations.
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Figure 23: MyD88-/- mice exhibit elevated serum IgE levels and circulating basophil populations
+/+

-/-

(a) Serum IgE from conventionally-reared (CNV) Myd88 (+/+) or Myd88 (-/-) mice as measured by ELISA. (b) Flow
+/+
-/cytometric analysis of blood basophils from CNV Myd88 or Myd88 mice. Numbers adjacent to outlined areas
indicate percent cells in each gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (c) Number of basophils per mL of
+/+
-/blood from CNV Myd88 or Myd88 mice. (d) Mean fluorescence intensity of surface-bound IgE on blood basophils
+/+
-/+/+
-/from CNV Myd88 or Myd88 mice as determined by flow cytometry (mean ± S.D.; Myd88 , n=4; Myd88 , n=4).
-/(e) Serum IgE levels from control (WT) or Nod1 mice as measured by ELISA. (f) Flow cytometric analysis of blood
-/-/basophils from control or Nod1 mice. (g) Number of basophils per mL of blood from control (WT) or Nod1 mice
-/(mean ± S.D.; WT, n=2-4; Nod1 , n=3-4). (h) Serum IgE from antibiotic-treated (ABX) mice treated with control or CpG
as measured by ELISA. (i) Flow cytometric analysis of blood basophils from CNV or ABX mice treated with control or
CpG. (j) Number of basophils per mL of blood from CNV or ABX mice treated with control or CpG. Data representative
of two or more independent experiments (mean ± S.D.; CNV, n=2-5; ABX, n=3-5; *, P ≤ 0.05).
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MyD88-dependent signaling in B cells can inhibit IgE class switching in vitro (Liu
et al. 2003). To test whether B cell-intrinsic MyD88-dependent signaling influenced IgE
production or basophil homeostasis in vivo, chimeras were generated by sorting and
adoptively transferring B or T cells from Myd88+/+ or Myd88-/- mice into Rag1-/- recipients
(Figure 24a). Compared to controls, mice that received Myd88-/- B cells with Myd88+/+ T
cells displayed elevated serum IgE levels (Figure 24b), increased frequencies (Figure
24c) and numbers (Figure 24d) of blood basophils, and increased basophil-surfacebound IgE levels (Figure 24e). Together, these results indicate that B cell-intrinsic
MyD88-dependent signaling limits steady-state serum IgE levels and circulating basophil
responses in vivo and implicates B cell-intrinsic recognition of commensal bacterialderived signals in mediating commensal-regulation of circulating basophils and basophilmediated TH2 cytokine-dependent allergic inflammation.
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Figure 24: B cell-intrinsic deletion of MyD88 results in elevated serum IgE levels and circulating
basophil populations
+/+

-/-

-/-

(a) Experimental diagram of sort and transfer of Myd88 or Myd88 , B or T cells into Rag1 recipients. (b) Serum IgE
+/+
-/from Rag1-/- mice reconstituted with Myd88 or Myd88 , B or T cells as measured by ELISA. (c) Flow cytometric
-/+/+
-/analysis of blood basophils from Rag1 mice reconstituted with Myd88 or Myd88 , B or T cells. Numbers adjacent
to outlined areas indicate percent cells in each gate. Gated on CD3 , CD4 , CD8 , CD19 , CD117 cells. (d) Number of
-/+/+
-/basophils per mL of blood from Rag1 mice reconstituted with Myd88 or Myd88 , B or T cells. (e) Mean
-/+/+
fluorescence intensity of surface-bound IgE on blood basophils from Rag1 mice reconstituted with Myd88 or
-/Myd88 , B or T cells as determined by flow cytometry. Data representative of three or more independent
experiments (mean ± S.D.; +/+B +/+T, n=1-4; +/+B -/-T, n=5-12; -/-B +/+T, n=4-12; *, P ≤ 0.05).

4.5 Discussion
Data in Chapter 3 identified a previously unreconized role for commensal bacterialderived signals in limiting steady-state serum IgE levels, circulating basophil populations,
and basophil-mediated allergic inflammation. However, the mechanisms by which
commensal bacterial-derived signals limit circulating basophil populations are not known.
Data presented in this chapter indicate that elevations in circulating basophil populations
observed upon antibiotic treatment of mice are critically dependent on IgE. This finding is
consistent with findings from other groups that indicate that IgE influences granulocyte
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homeostasis in the absence of an antigen (Lantz et al. 1997, Yamaguchi et al. 1997,
Saini et al. 2000). Though presented in the context of allergy here, the observation that
IgE alone is sufficient to increase the frequency and number of circulating basophils
implies that regulation of basophils by IgE is likely relevant in immunity to helminth
parasitic infections that are characterized by high serum IgE levels (Perona-Wright et al.
2008).
Data presented in this chapter also indicate that B cell-intrinsic MyD88
dependent signaling limits serum IgE levels and circulating basophil populations. It is
interesting to note that while serum IgE levels and circulating basophil frequencies and
numbers were significantly elevated in mice that received Myd88-/- B cells with Myd88+/+
T cells compared to controls, there was variation in these peramaters within
experimental groups. One potential explination for this variation is that IgE is not acting
directly on basophils to mediate their population expansion, but rather is acting indirectly
via one or more additional cell types or signaling molecules. Additionally, the TLR9dependent commensal-derived signal CpG was found to be sufficient to limit serum IgE
levels and circulating basophil populations in ABX-treated mice. CpG also reduced
circulating basophil populations in CNV-reared mice suggesting that either the CpGdependent pathways that limit these phenotypes are not saturated in CNV-reared mice,
or that CpG is influencing circulating basophils through additional mechanisms other
than suppression of serum IgE levels. Commensal-derived signals have been shown to
influence B cell homeostasis in other contexts. For example, class switching of B cells to
the IgA isotype and subsequent secretion of IgA into the intestinal lumen is dependent
on commensal-derived signals (Macpherson, Slack 2007). Interestingly, this effect is
mediated through both T cell-dependent and –independent mechanisms (Renshaw et al.
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1994, Macpherson et al. 2000, Macpherson, Uhr 2004a, Bergqvist et al. 2006) indicating
that innate recognition of commensal-derived signals is fundamental to B cell physiology.
However, unlike commensal-regulation of IgA responses which are limited to mucosal
tissues, a lack of commensal-regulation of IgE results in systemic elevations in serum
IgE levels (Macpherson, Uhr 2004a).
Over the past decade, advances in therapeutics for asthma and other allergic
diseases have been considerable, however, reliable interventions designed to prevent
the development of allergic diseases or the progression from one to multiple allergies
are yet to become a reality. Data presented in this chapter indicate that serum IgE
levels and blood basophil populations correlate in human patients with hyper-IgE
syndrome, and that treatment with Omalizumab reduces IgE-mediated increases in
circulating basophil populations. Additionally, data presented here indicate that steadystate serum IgE levels and circulating basophil populations were limited by B cellintrinsic MyD88 signaling pathways, providing insights into one cell-intrinsic mechanism
by which commensal-derived signals may influence serum IgE levels. Together, these
results provide therapeutically relevant insights into the cellular and molecular
mechanisms by which commensal bacterial-derived signals regulate circulating basophil
populations in the steady-state, and subsequently influence the development of TH2
cytokine-mediated inflammation in response to an allergen.
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Chapter 5: Summary, discussion and future
directions
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5.1 The influence of commensal bacteria on allergic inflammation
It has been nearly fifty years since the first examinations of TH2 cytokine-dependent
immune responses in germ-free animals performed by Wescott and colleagues using the
murine helminth parasite Nippostrongylus brasiliensis (Wescott, Todd 1964). Despite
this, subsequent study of the influence of commensal-derived signals on the
development and/or progression of TH2 cytokine-mediated inflammation required
technical advances in microbiology and immunology. It was not until the early 1980’s,
when Wannemuehler et. al. described an impaired ability for germ-free mice to induce
systemic tolerance to oral antigens (Wannemuehler et al. 1982), that this field again
began to garner attention. Wannemuehler went on to show that LPS, a commensal
bacterial-derived signal from gram negative bacteria, was sufficient to induce oral
tolerance to systemically administered sheep erythrocytes in germ-free animals
(Wannemuehler et al. 1982). Sudo et. al. expanded on these initial observations using
an OVA oral tolerance model by showing that germ-free mice develope robust total IgE,
and OVA-specific IgE and IgG1 but not IgG2a responses compared to conventionallyreared mice (Sudo et al. 1997). Sudo went on to show that exaggerated Ig response in
OVA-challenged mice correlated with increased production of IL-2, IL-4 and TGF-β by
splenocytes when cultured with OVA antigen.
Subsequent mechanistic studies focused on identifying the specific microbialderived signals and their receptors responsible for promoting oral tolerance. TLR4defective mice were shown to have elevated allergic responses to peanut allergens coadministered orally with cholera toxin (Bashir et al. 2004). Antibiotic treatment of TLR4sufficient mice recapitulated the elevated IgE levels seen in TLR-4-defective mice
suggesting that commensal-derived LPS contributed to steady-state tolerance to food
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antigens (Bashir et al. 2004). These results are consistent with Wannemuehler initial
observation that LPS could induce oral tolerance in germ-free animals (Wannemuehler
et al. 1982). The failure of oral tolerance induction in germ-free mice was also found to
correlate with the absence of Peyer’s patch T cells (Maeda et al. 2001), however,
subsequent studies indicated that antigen-specific T cell tolerance to oral OVA was
intact in germ-free mice (Walton et al. 2006a). Together, these findings indicated that
commensal bacterial-derived signals influenced humoral oral tolerance more strongly
than cellular oral tolerance, and prompted subsequent studies of how the innate immune
system senses and responds to commensal-derived signals to influence allergic
responses.
Beyond the field of oral tolerance, the majority of progress made in
understanding the role that commensal-derived signals play in modulating allergic
immune responses have come in the past 10 years from epidemiologic studies of human
patients. Kalliomäki et. al. identified associations between alterations in commensalbacterial populations and the subsequent development of allergic disease (Kalliomaki et
al. 2001) and allergic patients were shown to have altered commensal bacterial
community structure in the intestine compared to healthy controls (Penders et al. 2007).
These findings implicate commensal bacterial-derived signals in influencing susceptibility
to allergic disease in humans. More recently, antibiotic exposure in children was shown
to significantly correlate with increased risk of developing asthma or eczema (Marra et
al. 2009, Kummeling et al. 2007, Verhulst et al. 2008) suggesting that normal
commensal-bacterial communities are important for protecting against the development
allergies.

124

Despite these epidemiologic advances, mechanistic understandings of the
mechanisms by which commensal-bacterial derived signals influence TH2 cytokinedependent allergic inflammation using animal models have been lacking. In one nice
study Noverr and colleagues used an allergic airway model to show that antibiotic
treatment of conventionally-reared mice resulted in exaggerated IL-13-mediated airway
inflammation (Noverr et al. 2005). Similar results were obtained using the ovalbuminaluminum allergic airway model (Herbst et al. 2011). However, these studies provide
only limited understanding of the mechanisms by which the innate immune system
recognizes commensal bacterial-derived signals and modulates the development of
allergic TH2 cytokine-dependent allergic inflammation.

5.2 The influence of antibiotics on intestinal bacteria
One limitation of previous studies that utilized antibiotic treatment in animal models is
that they did not include a thorough characterization of the influence antibiotic treatment
has on commensal bacterial communities. We therefore first carried out an in depth
characterization of the effects of oral antibiotic treatment bacterial communities that
colonize the murine intestine. Because a large percentage of intestinal bacteria are
anaerobes that lack the enzymes necessary for the detoxification of oxygen, we opted
for 454 deep sequencing molecular biologic methods in lieu of classical culture-based
methods (Adlerberth, Wold 2009).
We initially adopted an antibiotic treatment protocol similar to previously
published protocols (Sekirov et al. 2008, Bashir et al. 2004, Rakoff-Nahoum et al. 2004,
Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008). While this treatment protocol was
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highly effective and reduced intestinal bacteria to the extent that DNA from food
composed the majority of recovered 16S rDNA sequences, it was associated with animal
dehydration that could complicate the interpretation of subsequent studies (Guseinov,
Guseinova 2008). This finding highlights the need for minimizing or controlling for
unintentional side-effects of antibiotic treatment that may confound results and
interpretations. For example, in addition to potential for dehydration, commensal-derived
signals have been shown to modulate nutrition and metabolism (Ley et al. 2005, Bollyky
et al. 2009), fundamental aspects of mammalian physiology that likely influence the
immune system. The utilization of both gain and loss of function approaches, such as
conventional mouse strains deficient in innate pattern recognition receptors, can
complement antibiotic-treated and germ-free mouse models to help control for some of
these effects.
To circumnavigate potential complications of dehydration, acute administration of
broad-spectrum antibiotics by gavage was employed, while allowing animal access to
untreated drinking water; more closely mimicking antibiotic administration in humans.
Antibiotic treatment by oral gavage reduced absolute bacterial numbers and mimicked
anatomic, histologic and immunologic characteristics of reduced bacterial stimulation
observed in germ-free mice. UniFrac analysis of bacterial communities indicated that
antibiotic treatment promoted a novel community structure in the intestine that was more
similar between antibiotic-treated samples as compared to samples from control-treated
animals. Importantly, temporal analysis of stool pellet bacterial communities during
treatment revealed a fast restructuring in community structure after only one day of
antibiotic treatment. These findings indicate that even short exposure to oral antibiotics
dramatically alters intestinal bacterial communities of the murine intestine and supposes
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that similarly short courses of antibiotics in patients (days to weeks) might also
significantly alter commensal community structure.
Early colonization with Bacteroides fragilis has been implicated as a risk factor
for asthma development in humans (Vael et al. 2008). As such, the effects of antibiotic
treatment on members of the Bacteroidies phylum were examined. Members of the
Bacteroidies phylum, namely the Bacteroidales order, represented 60-70% of intestinal
bacteria in control-treated animals. After one day, these bacteria represented a
combined frequency of greater than 95% in samples from antibiotic-treated but not
control-treated animals, and subsequently stabilized at a frequency of approximately
90% in all sampled compartments. It is intriguing to speculate that rapid increases in
Bacteroidies frequency after antibiotic initiation may be responsible for associations
between early antibiotic exposure in humans and increased susceptibility to allergic
inflammation.
Naïve animals displayed significantly higher frequencies of Lactobacillus species
in mucosal-associated as compared to luminal communities and Lactobacillus species
were significantly reduced in frequency with antibiotic treatment. Lactobacillus species
have been cited as ―probiotic‖ bacteria with mixed effectiveness in treating human
diseases (Betsi, Papadavid & Falagas 2008, Kozuch, Hanauer 2008). It may therefore
be useful to examine whether reductions in this potentially beneficial mucosal-associated
bacterial group are related to changes in immune cell homeostasis observed following
antibiotic treatment. The mucosal-associated anatomical location of this bacterium also
suggests that colonization of this anatomical location may be relevant for the beneficial
host effects of this species. This is consistent with recent observations that segmented
filamentous bacteria exist in an intimate relationship with the intestinal epithelium where
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they regulate TH17 and Treg cell populations (Gaboriau-Routhiau et al. 2009, Ivanov et
al. 2009, Wu et al. 2010, Kriegel et al. 2011). Together, these findings indicate that
antibiotic treatment results in temporal and spatial alterations to bacterial communities
that colonize the mammalian intestine.

5.3 Basophils as a mediator of commensal-bacterial effects
Antibiotic-treated and germ-free mice were found to have elevated steady-state serum
IgE levels and a selective population expansion of circulating basophils compared to
conventionally-reared mice. Interestingly, elevations in basophils were limited to the
blood and spleen, and were not observed in tissue or lymphoid tissues, indicating that
steady-state effects of commensal-derived signals on basophils are compartmentalized
to these anatomical sites. These findings are of particular interest given that basophils
can be directly activated by allergens and contribute to the development of optimal TH2
cytokine-dependent allergic inflammation (Gessner, Mohrs & Mohrs 2005, Mohrs et al.
2005, Min et al. 2004). Additionally, and perhaps more importantly, basophils have been
shown to function as accessory cells by providing early sources of IL-4 and contributing
to the initiation and/or propagation of CD4+ TH2 cell responses (Hida et al. 2005, Oh et
al. 2007). Finally, basophils have been shown to endocytose soluble antigen, express
MHC II and co-stimulatory molecules, and in select cases, act as antigen presenting
cells that promote antigen-specific TH2 cell differentiation (Perrigoue et al. 2009, Sokol et
al. 2009, Yoshimoto et al. 2009). Regardless of whether basophils are sufficient to
initiate and/or propagate TH2 cell responses, their ability to augment TH2 cell
differentiation in response to an allergic stimulus identifies basophils as a key player
determining whether an encounter with an allergen results in the development of a TH2
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cell response. As such, the observation that basophils are selectively expanded in
antibiotic-treated or germ-free mice provides a mechanism to explain correlations
between antibiotic treatment and increased susceptibility to allergic diseases in human
patients.
We tested whether the elevations in steady-state basophils observed in
antibiotic-treated mice contributed to the development of allergic inflammation using
three basophil-mediated allergy models. Antibiotic-treated mice displayed exaggerated
basophil responses and inflammation in a skin model of MC903-induced atopic
dermatitis.

Additionally,

antibiotic-treated

mice

displayed

exaggerated

basophil

responses and lung inflammation using a house dust mite-elicited allergic airway model.
In both cases, basophils may be contributing to the development of TH2 cytokinemediated inflammation by either by augmenting the development of the TH2 cell
response or by being recruited to the site of tissue inflammation where they may be
exerting more classical effector cell functions such as the release of histamine,
leukotrienes, cytokines or chemokines. The differential contribution of basophils to the
allergic inflammation observed in these models was not directly tested here, and could
be explored in future studies.
To directly test whether the elevated steady-state basophil responses observed
in antibiotic-treated mice were contributing to the development of T H2 cell responses, we
utilized the protease allergen papain. ABX-treated mice displayed elevated basophil LN
recruitment and exaggerated LN TH2 cell responses to papain compared to CNV-reared
mice. Non-basophil APC populations were not significantly influenced by antibiotictreatment in our experimental systems, however, they may contribute to exaggerated
allergic responses in antibiotic-treated or germ-free mice in other settings. Basophils
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were shown to be critical contributors to the exaggerated allergen-induced TH2 cell
responses observed in antibiotic-treated mice using two methods of basophil depletion.
Together, these findings indicate that commensal-derived signals limit basophil effector
function and basophil-mediated TH2 cell responses, and identify basophils as a potential
therapeutic target, the manipulation of which may prevent the development or
propagation of allergic diseases in patients.

5.4 Regulation of circulating basophil populations by IgE
Natural IgE is produced in the absence of allergic stimuli and lacks antigen specificity,
implicating IgE in functions other than antigen detection. Consistent with this hypothesis,
IgE has been found to influence multiple aspects of granulocyte homeostasis in the
absence of an antigen including regulation of surface protein expression, cell survival,
and cell adhesion (Galli et al. 2005, Xiang, Moller & Nilsson 2006, Kitaura et al. 2005).
We found that steady-state serum IgE levels correlate with circulating basophil
populations in mice with reduced commensal stimulation and humans with hyper-IgE
syndrome. IgE was found to be critical for elevations in circulating basophils observed
with antibiotic treatment of mice, and IgE was sufficient to elevate murine circulating
basophil populations. Although presented in the context of allergy here, the observation
that IgE alone can increase the frequency and number of circulating basophils implies
that regulation of basophils by IgE is likely relevant in immunity to helminth parasitic
infections that are characterized elevations in serum IgE (Perona-Wright et al. 2008).
We found that B cell-intrinsic MyD88 dependent signaling limits serum IgE levels
and circulating basophil populations in vivo and CpG was found to be sufficient to limit
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serum IgE levels and circulating basophil populations. These findings implicate direct
detection of commensal-derived signals by B cells in limiting IgE class switching and
production, raising the question as to where B cells interact with commensal-derived
signals. One possibility is that B cells circulate through intestinal-associated
compartments such as the lamina propria where they are exposed to commensal
bacterial-derived signals (Figure 25). Alternatively, B cells may encounter commensalderived signals trafficked to the mesenteric lymph nodes by dendritic cells or other
mechanisms. Finally, commensal-derived signals may be present systemically at high
enough levels to impart effects on B cell populations.

5.5 Final thoughts
Over the past decade, advances in therapeutics for asthma and other allergic diseases
have been considerable, however, reliable interventions designed to prevent the
development of allergic diseases or the progression from one to multiple allergies are yet
to become a reality.

Data presented in this thesis indicate that commensal-derived

signals limit serum IgE levels and circulating basophil populations in the steady-state.
Antibiotic-treated mice displayed exaggerated TH2 cytokine-dependent inflammation in
two models of basophil-mediated allergic disease and basophils were shown to
contribute directly to the development of exaggerated TH2 cell responses in this setting.
Together, these results provide therapeutically relevant insights into one mechanism by
which commensal bacterial-derived signals influence susceptibility to the development of
a TH2 cell response, and to TH2 cytokine-dependent allergic inflammation. It is hoped
that identification of this commensal-basophil-TH2 cell axis will stimulate studies by other
investigators aimed at exploiting this knowledge to develop new preventative or
therapeutic approaches for allergic diseases.
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Figure 25: Summary of thesis
Commensal bacterial-derived signals act via B cell-intrinsic, MyD88-dependent signaling pathways to limit B cell
production of IgE. B cells may detect commensal signals in intestinal compartments (1) or systemically (2). (3) In the
absence of commensal signals, B cells produce increased amounts of IgE which enters the circulation. (4) IgE acts to
expand the number of circulating basophils in the steady-state. (5) In the event of allergen exposure, basophils are
recruited to draining lymph nodes or sites of tissue inflammation where they contribute to the generation of TH2 cell
responses and/or TH2 cytokine-dependent allergic inflammation. Adapted from (Hill, Artis 2010).
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